ААР — Американская академия педиатрии (American Academy of Pediatrics)
ABC — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение» (Airways-Breathing-Circulation)
АВСА3 — белковый член АТФ-связывающей кассеты АЗ
АВСВ11 — ген АТФ-связывающей кассеты, 11-й член подсемейства В (ATP-binding cassette, subfamily В member 11)
АВСВ4 — ген АТФ-связывающей кассеты, 4-й член подсемейства В (ATP-binding cassette 4 gene)
АВСС2 — ген, кодирующий 2-й член подсемейства С ABCDE — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение-неврологический статус-внешний вид» (Airways-Breathing-Circulation-Disability-Exposure)
ABCG5/G8 — гетеродимер переносчика АТФ-связывающей кассеты ABCG5 и ABCG8 (Th eheterodimer of ATP-binding cassette transporter ABCG5 and ABCG8)
AC — до еды (при назначениях) — ante cibum
АСЕР — Американская коллегия врачей неотложной помощи (American College of Emergency Physicians)
ACOG — Американская коллегия акушеров и гинекологов (American College of Obstetricians and Gynecologists)
AHA — Американская кардиологическая ассоциация (American Heart Association)
AIS — аденокарцинома in situ (adenocarcinoma in situ)
ALTE — очевидное опасное для жизни событие (apparent life-threatening event)
APLS — курсы расширенных реанимационных мероприятий в педиатрии, спонсируемые Американской академией педиатрии и Американской коллегией врачей неотложной помощи (Advanced Pediatric Life Support)
AUC — площадь под фармакокинетической кривой (area under the curve)
AVPU — шкала для оценки уровня сознания («в ясном сознании»; «реакция на вербальные раздражители»; «реакция на боль»; «без сознания») (alert, verbal, pain, unresponsive)
ABCC2 - АТФ-связывающих кассет (ATP-binding cassette sub-family C member 2)
mTOR — мишень рапамицина в клетках млекопитающих (mammalian target ofrapamycin)
NB! — важно, обратить внимание (Nota bene)
NCI — Национальный институт рака (National Cancer Institute)
NICE — Национальный институт здоровья и клинического совершенствования (качества медицинской помощи) Великобритании (National Institute for Health and Clinical Excellence)
NK — естественные клетки-киллеры (natural killer)
NMDA — N-метил-D-аспартат (N-methyl-D-aspartate)
NMDA — N-метил-D-аспартатные рецепторы
NNT — число больных, которых необходимо пролечить, чтобы достичь какого-то указанного эффекта (Number Need to Treatment)
OR — отношение шансов (odds ratio)
paCO2 — парциальное давление углекислого газа в артериальной крови
PALS — курсы расширенных реанимационных мероприятий в педиатрии (Pediatric Advanced Life Support)
PANDAS — аутоиммунное нейропсихиатрическое расстройство в детском возрасте, ассоциированное со стрептококковой инфекцией (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
PANS — острый нейропсихиатрический синдром в детском возрасте (Pediatric acute-onset neuropsychiatric syndrome)
paO2 — парциальное давление кислорода в артериальной крови
PAS — фуксинсернистая кислота, реактив Шиффа (periodic acid-Shiff)
PC — после еды (при назначениях) — post cibum рСO2 — парциальное давление углекислого газа PCSK-9 — пропротеиновая конвертаза субтилизин-кексинового типа 9 (proprotein convertase subtilisin/kexin type 9)
PD — плотность мощности (power density)
PD-1 — программируемая клеточная смерть 1 (англ. programmed cell death 1)
PFAPA — периодическая лихорадка с афтозным стоматитом, фарингитом и лимфаденитом (Periodic Fevers with Aphthous stomatitis, Pharyngitis and Adenitis)
PIM — показатель летального исхода у детей (Pediatric Index of Mortality)
piO2 — парциальное давление кислорода
во вдыхаемом воздухе
рО2 — парциальное давление кислорода
POLG — субъединица ДНК-полимеразы у
POP — пролапс тазовых органов (pelvic organ prolapse) POP-Q — количественная оценка пролапса тазовых органов (Pelvic Organ Prolapse Quantification)
PRISA II — оценка риска госпитализации у детей II (Pediatric Risk of Admission)
PRISM — риск летального исхода у детей (Pediatric Risk of Mortality)
PRN — при (по) необходимости (Pro re nata — при возникновении обстоятельств)
PRSS — ген сериновой протеазы
PS. — примечание (Post scriptum)
PUVA-терапия — псорален-ультрафиолет А-терапия (psoralen and ultraviolet А)
Q#H — каждые # часов (при назначениях) — quaque... hora
QAM — каждое утро (при назначениях) — quaque ante meridiem
QPM — каждый вечер (при назначениях) — quaque post meridiem
RAG — ген, активирующий рекомбиназу
REMS — Программа по оценке и снижению риска (Risk Evaluation and Mitigation Strategy)
RePEAT — пересмотренный инструмент для оценки педиатрической неотложной медицинской помощи (Revised Pediatric Emergency Assessment Tool)
RF — ревматоидный фактор
Rh — резус(-фактор)
Rh«+» — резус-положительный
Rh«-» — резус-отрицательный
ROCA — Алгоритм риска развития рака яичников (Risk of Ovarian Cancer Algorithm)
ROHHAD — быстро развивающееся ожирение с дисфункцией гипоталамуса, гиповентиляцией и спонтанной дисрегуляцией (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
ROMA — Алгоритм риска наличия злокачественной опухоли яичника (Risk of Ovarian Malignancy Algorithm)
RR — относительный риск (relative risk или risk ratio)
RW — реакция Вассермана (reaction of Wassermann)
SaO2 — сатурация артериальной крови кислородом
SatO2 — насыщение крови кислородом
SCJ — зона перехода плоского эпителия в цилиндрический (Scuamocolumnar Junction)
ScvO2 — насыщение кислородом центральной венозной крови (central venous oxygen saturation)
SD — стандартное отклонение (standart deviation) SEER — эпидемиология эпиднадзора и данных о конечных результатах (Surveillance Epidemiology and End Result)
SFTPA — ген сурфактантного белка A
SFTPB — ген сурфактантного белка В
SFTPC — ген сурфактантного белка С
SILS — хирургия единого лапароскопического доступа (single-incision laparoscopic surgery)
В ходе подготовки статей по гинекологии для пользователей сайта МедУнивер использованы труды следующих авторов:
Adelman M.R., Dassel M.W., Sharp H.T. Management of complications encountered with Essure hysteroscopic sterilization: a systematic review // J. Minim. Invasive Gynecol. 2014. Vol. 21. N. 5. P. 733.
Akers A.Y., Steinway C., Sonalkar S. et al. Reducing pain during intrauterine device insertion: a randomized controlled trial in adolescents and young women // Obstet. Gynecol. 2017. Vol. 130. N. 4. P. 795.
Alvarez F., Brache V., Fernandez E. et al. New insights on the mode of action of intrauterine contraceptive devices in women // Fertil. Steril. 1988. Vol. 49. N. 5. P. 768.
American Academy of Pediatrics: Contraception for adolescents // Pediatrics. 2014. Vol. 134. N. 4. P. e1244.
American College of Obstetricians and Gynecologists: Long-acting reversible contraception: implants and intrauterine devices // Practice Bulletin. N. 186. November 2017.
American College of Obstetricians and Gynecologists: Adolescents and long-acting reversible contraception: implants and intrauterine devices // Committee Opinion. N. 735. May 2018.
American College of Obstetricians and Gynecologists: Emergency contraception // Practice Bulletin. N. 152. September 2015, Reaffirmed 2018.
American College of Obstetricians and Gynecologists: Prevention of infection after gynecologic procedures // Practice Bulletin. N. 195. June 2018.
American College of Obstetricians and Gynecologists: Benefits and risks of sterilization // Practice Bulletin. N. 208. March 2019.
American College of Obstetricians and Gynecologists: Clinical challenges of long-acting reversible contraceptive methods // Committee Opinion. N. 672. September 2016, Reaffirmed 2019.
American College of Obstetricians and Gynecologists: Depot medroxyprogesterone acetate and bone effects // Committee Opinion. N. 602. June 2014, Reaffirmed 2019c.
American College of Obstetricians and Gynecologists: Use of hormonal contraception in women with coexisting medical conditions // Practice Bulletin. N. 206. February 2019.
American Society for Reproductive Medicine: Vasectomy reversal // Fertil. Steril. 2008. Vol. 90. N. 5. P. S78.
Amundsen G.A., Ramakrishnan K. Vasectomy: a “seminal” analysis // South Med. J. 2004. Vol. 97. P. 54.
Back D.J., Breckenridge A.M., Crawford F.E. et al. The effect of rifampicin on the pharmacokinetics of ethynyl estradiol in women // Contraception. 1980. Vol. 21. N. 2. P. 135.
Bahamondes L., Del Castillo S., Tabares G. et al. Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years // Contraception. 2001. Vol. 64. N. 4. P. 223.
Bahamondes L., Faundes A., Sobreira-Lima B. et al. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age // Contraception. 2005. Vol. 72. N. 5. P. 337.
Balci O., Mahmoud A.S., Capar M. et al. Diagnosis and management of intra-abdominal, mislocated intrauterine devices // Arch. Gynecol. Obstet. 2010. Vol. 281. N. 6. P. 1019.
Barnett C., Moehner S., Do Minh T. et al. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study // Eur. J. Contracept. Reprod. Health Care. 2017. Vol. 22. N. 6. P. 424.
Bednarek P.H., Creinin M.D., Reeves M.F. et al. Immediate versus delayed IUD insertion after uterine aspiration // N. Engl. J. Med. 2011. Vol. 364. N. 23. P. 2208.
Beksinska M.E., Smit J.A., Kleinschmidt I. et al. Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception // Contraception. 2010. Vol. 81. N. 1. P. 30.
Berry-Bibee E.N., Kim M.J., Tepper N.K. et al. Co-administration of St. John’s wort and hormonal contraceptives: a systematic review // Contraception. 2016. Vol. 94. N. 6. P. 668.
Betrabet S.S., Shikary Z.K., Toddywalla V.S. et al. ICMR Task Force Study on hormonal contraception. Transfer of norethindrone (NET) and levonorgestrel (LNG) from a single tablet into the infant’s circulation through the mother’s milk // Contraception. 1987. Vol. 35. P. 517.
Bounds W., Guillebaud J., Dominik R. et al. The diaphragm with and without spermicide. A randomized, comparative efficacy trial // J. Reprod. Med. 1995. Vol. 40. P. 764.
Brache V., Cochon L., Jesam C. et al. Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture // Hum. Reprod. 2010. Vol. 25. N. 9. P. 2256.
Bradshaw H.D., Rosario D.J., James M.J. et al. Review of current practice to establish success after vasectomy // Br. J. Surg. 2001. Vol. 88. P. 290.
Brahmi D., Steenland M.W., Renner R.M. et al. Pregnancy outcomes with an IUD in situ: a systematic review // Contraception. 2012. Vol. 85. N. 2. P. 131.
Briggs G.G., Freeman R.K., et al. Drugs in Pregnancy and Lactation. Philadelphia: Wolters Kluwer, 2017. 1025 p.
Brohet R.M., Goldgar D.E., Easton D.F. et al. Oral contraceptives and breast cancer risk in the international BRCA 1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group // J. Clin. Oncol. 2007. Vol. 25. P. 5327.
Brunner L.R., Hogue C.J. The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth // Ann. Epidemiol. 2005. N. 15. P. 492.
Bryant A.G., Lyerly A.D., DeVane-Johnson S. et al. Hormonal contraception, breastfeeding and bedside advocacy: the case for patient-centered care // Contraception. 2019. Vol. 99. N. 2. P. 73.
Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Development: Combination oral contraceptive use and the risk of endometrial cancer // JAMA 1987. Vol. 257. P. 796.
Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Development: The reduction in risk of ovarian cancer associated with oral-contraceptive use // N. Engl. J. Med. 1987. Vol. 316. P. 650.
Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, 2015 // MMWR 2015. Vol. 64. N. 3. P. 1.
Chan L.M., Westhoff C.L. Tubal sterilization trends in the United States // Fertil. Steril. 2010. Vol. 94. N. 1. P. 1.
Charlton B.M., M?lgaard-Nielsen D., Svanstr?m H. et al. Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study // BMJ 2016. Vol. 352. P. h6712.
Chasan-Taber L., Willett W.C., Manson J.E. et al. Prospective study of oral contraceptives and hypertension among women in the United States // Circulation. 1996. Vol. 94. P. 483.
Chen B.A., Reeves M.F., Hayes J.L. et al. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial // Obstet. Gynecol. 2010. Vol. 116. N. 5. P. 1079.
Chudnoff S.G., Nichols J.E. Jr., Levie M. Hysteroscopic Essure inserts for permanent contraception: extended follow-up results of a phase III multicenter international study // J. Minim. Invasive Gynecol. 2015. Vol. 22. N. 6. P. 951.
Clark M.K., Sowers M., Levy B. et al. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate // Fertil. Steril. 2006. Vol. 86. N. 5. P. 1466.
Clark N.V., Rademaker D., Mushinski A.A. et al. Essure removal for the treatment of device-attributed symptoms: an expanded case series and follow-up survey // J. Minim. Invasive Gynecol. 2017. Vol. 24. N. 6. P. 971.
Cleland K., Zhu H., Goldstuck N. et al. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience // Hum. Reprod. 2012. Vol. 27. N. 7. P. 1994.
Collaborative Group on Epidemiological Studies of Ovarian Cancer: Ovarian cancer and oral contraceptives: collaborative reanalysis of data of 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls // Lancet. 2008. Vol. 371. P. 303.
Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies // Lancet. 1996. Vol. 347. P. 1713.
Costello C., Hillis S., Marchbanks P. et al. The effect of interval tubal sterilization on sexual interest and pleasure // Obstet. Gynecol. 2002. N. 100. P. 3.
Creinin M.D., Schlaff W., Archer D.F. et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial // Obstet. Gynecol. 2006. Vol. 108. N. 5. P. 1089.
Cromer B.A., Smith R.D., Blair J.M. et al. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception // Pediatrics. 1994. N. 94. P. 687.
Croxatto H.B., Ortiz M.E., Muller A.L. Mechanisms of action of emergency contraception // Steroids. 2003. Vol. 68. P. 1095.
Curtis K.M., Tepper N.K., Jatlaoui T.C. et al. U.S. medical eligibility criteria for contraceptive use, 2016 // MMWR 2016. Vol. 65. N. 3. P. 1.
Daniels K., Daugherty J., Jones J. et al. Current contraceptive use and variation by selected characteristics among women aged 15–44: United States, 2011–2013 // Natl. Health Stat. Report. 2015. Vol. 86. P. 1.
de Villiers E.M. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma // Int. J. Cancer. 2003. Vol. 103. N. 6. P. 705.
Deffieux X., Morin Surroca M., Faivre E. et al. Tubal anastomosis after tubal sterilization: a review // Arch. Gynecol. Obstet. 2011. Vol. 283. N. 5. P. 1149.
DeStefano F., Perlman J.A., Peterson H.B. et al. Long term risk of menstrual disturbances after tubal sterilization // Am. J. Obstet. Gynecol. 1985. Vol. 152. P. 835.
Dorflinger L.J. Metabolic effects of implantable steroid contraceptives for women // Contraception. 2002. Vol. 65. N. 1. P. 47.
Edelman A.B., Carlson N.E., Cherala G. et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity // Contraception. 2009. Vol. 80. N. 2. P. 119.
Ellertson C., Evans M., Ferden S. et al. Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours // Obstet. Gynecol. 2003. Vol. 101. P. 1168.
Erickson B.K., Conner M.G., Landen C.N. Jr: The role of the fallopian tube in the origin of ovarian cancer // Am. J. Obstet. Gynecol. 2013. Vol. 209. N. 5. P. 409.
Falconer H., Yin L., Gr?nberg H. et al. Ovarian cancer risk after salpingectomy: a nationwide population-based study // J. Natl. Cancer Inst. 2015. Vol. 107. N. 2.
Fernandez H., Legendre G., Blein C. et al. Tubal sterilization: pregnancy rates after hysteroscopic versus laparoscopic sterilization in France, 2006–2010 // Eur. J. Obstet. Gynecol. Reprod. Biol. 2014. Vol. 180. P. 133.
Festin M.P.R., Peregoudov A., Seuc A. et al. Effect of BMI and body weight on pregnancy rates with LNG as emergency contraception: analysis of four WHO HRP studies // Contraception. 2017. Vol. 95. N. 1. P. 50.
Findley A.D., Siedhoff M.T., Hobbs K.A. et al. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial // Fertil. Steril. 2013. Vol. 100. N. 6. P. 1704.
Finer L.B., Zolna M.R. Declines in unintended pregnancy in the United States, 2008–2011 // N. Engl. J. Med. 2016. Vol. 374. N. 9. P. 843.
Finer L.B., Zolna M.R. Unintended pregnancy in the United States: incidence and disparities, 2006 // Contraception. 2011. Vol. 84. N. 5. P. 478.
Fiorino A.S. Intrauterine contraceptive device–associated actinomycotic abscess and Actinomyces detection on cervical smear // Obstet. Gynecol. 1996. Vol. 87. P. 142.
Food and Drug Administration: Drug safety communication: updated information about the risk of blood clots in women taking birth control pills containing drospirenone // Rockville, Food and Drug Administration, 2012.
Fox M.C., Oat-Judge J., Severson K. et al. Immediate placement of intrauterine devices after first and second trimester pregnancy termination // Contraception. 2011. Vol. 83. N. 1. P. 34.
Furlong L.A. Ectopic pregnancy risk when contraception fails // J. Reprod. Med. 2002. Vol. 47. P. 881.
Gaffield M.E., Culwell K.R., Lee C.R. The use of hormonal contraception among women taking anticonvulsant therapy // Contraception. 2011. Vol. 83. N. 1. P. 16.
Gallo M.F., Grimes D.A., Lopez L.M. et al. Non-latex versus latex male condoms for contraception // Cochrane Database Syst. Rev. 2006. N. 1. P. CD003550.
Gallo M.F., Lopez L.M., Grimes D.A. et al. Combination contraceptives: effects on weight // Cochrane Database Syst. Rev. 2014. N. 1. P. CD003987.
Ganer Herman H., Gluck O., Keidar R. et al. Ovarian reserve following cesarean section with salpingectomy vs tubal ligation: a randomized trial // Am. J. Obstet. Gynecol. 2017. Vol. 217. N. 4. P. 472.
Gardner J.M., Mishell D.R. Jr. Analysis of bleeding patterns and resumption of fertility following discontinuation of a long-acting injectable contraceptive // Fertil. Steril. 1970. N. 21. P. 286.
Gariepy A.M., Creinin M.D., Smith K.J. et al. Probability of pregnancy after sterilization: a comparison of hysteroscopic versus laparoscopic sterilization // Contraception. 2014. Vol. 90. N. 2. P. 174.
Glasier A.F., Cameron S.T., Fine P.M. et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis // Lancet. 2010. Vol. 375. N. 9714. P. 555.
Gockley A.A., Elias K.M. Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction // Cancer Treat. Rev. 2018. Vol. 69. P. 66.
Godfrey E.M., Folger S.G., Jeng G. et al. Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review // Contraception. 2013. Vol. 87. N. 5. P. 549.
Goodman S., Henlish S.K., Reeves M.F. et al. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion // Contraception. 2008. Vol. 78. P. 143.
Grimes D.A., Hubacher D., Lopez L.M. et al. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use // Cochrane Database Syst. Rev. 2006. N. 4. P. CD006034.
Gurtcheff S.E., Turok D.K., Stoddard G. et al. Lactogenesis after early postpartum use of the contraceptive implant: a randomized controlled trial // Obstet. Gynecol. 2011. Vol. 117. N. 5. P. 1114.
Guttmacher Institute: Contraceptive use in the United States. 2018.
Guttmacher Institute: An overview of consent to reproductive health services by young people. 2014.
Haider S., Darney P.D. Injectable contraception // Clin. Obstet. Gynecol. 2007. Vol. 50. N. 4. P. 898.
Halpern V., Grimes D.A., Lopez L. et al. Strategies to improve adherence and acceptability of hormonal methods of contraception // Cochrane Database Syst. Rev. 2013. N. 10. P. CD004317.
Hannaford P.C., Kay C.R., Vessey M.P. et al. Combined oral contraceptives and liver disease // Contraception. 1997. Vol. 55. P. 145.
Hannaford P.C., Selvaraj S., Elliott A.M. et al. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioners oral contraception study // BMJ 2007. Vol. 335. N. 7621. P. 651.
Harel Z., Johnson C.C., Gold M.A. et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections // Contraception. 2010. Vol. 81. N. 4. P. 281.
Heikinheimo O., Gissler M., Suhonen S. Age, parity history of abortion and contraceptive choices affect the risk of repeat abortion // Contraception. 2008. Vol. 78. P. 149.
Heinemann L.A., Weimann A., Gerken G. et al. Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control study / Eur. J. Contracept. Reprod. Health Care. 1998. Vol. 3. N. 4. P. 194.
Hidalgo M.M., Lisondo C., Juliato C.T. et al. Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants // Contraception. 2006. Vol. 73. N. 5. P. 532.
Hillis S.D., Marchbanks P.A., Tylor L.R. et al. Poststerilization regret: findings from the United States Collaborative Review of Sterilization // Obstet. Gynecol. 1999. Vol. 93. P. 889.
Hillis S.D., Marchbanks P.A., Tylor L.R. et al. Tubal sterilization and long-term risk of hysterectomy: findings from the United States Collaborative Review of Sterilization // Obstet. Gynecol. 1997. Vol. 89. N. 4. P. 609.
Holt S.K., Salinas C.A., Stanford J.L. Vasectomy and the risk of prostate cancer // J. Urol. 2008. Vol. 180. N. 6. P. 2565.
Holt V.L., Scholes D., Wicklund K.G. et al. Body mass index, weight, and oral contraceptive failure risk // Obstet. Gynecol. 2005. Vol. 105. P. 46.
Inki P., Hurskainen R., Palo P. et al. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy // Ultrasound Obstet. Gynecol. 2002. Vol. 20. N. 4. P. 381.
International Collaboration of Epidemiological Studies of Cervical Cancer: Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies // Lancet. 2007. Vol. 370. P. 1609.
Jain J., Dutton C., Nicosia A. et al. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera // Contraception. 2004. Vol. 70. N. 1. P. 11.
Jamieson D.J., Kaufman S.C., Costello C. et al. A comparison of women’s regret after vasectomy versus tubal sterilization // Obstet. Gynecol. 2002. Vol. 99. P. 1073.
Jensen J.T., Burke A.E., Barnhart K.T. et al. Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis // Contraception. 2008. Vol. 78. N. 6. P. 451.
Jick S.S., Hagberg K.W., Kaye J.A: ORTHO EVRA and venous thromboembolism: an update // Contraception. 2010. Vol. 81. N. 5. P. 452.
Jick S.S., Hernandez R.K. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data // BMJ 2011. Vol. 342. P. d2151.
Kamencic H., Thiel L., Karreman E. et al. Does Essure cause significant de novo pain? A retrospective review of indications for second surgeries after Essure placement // J. Minim. Invasive Gynecol. 2016. Vol. 23. N. 7. P. 1158.
Kapp N., Curtis K.M. Hormonal contraceptive use among women with liver tumors: a systematic review // Contraception. 2009. Vol. 80. N. 4. P. 387.
Kapp N., Tilley I.B., Curtis K.M. The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: a systematic review // Contraception. 2009. Vol. 80. N. 4. P. 381.
Kaunitz A.M. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer // J. Reprod. Med. 1996. N. 45. P. 419.
Kavanaugh M.L., Jerman J. Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014 // Contraception. 2018. Vol. 97. N. 1. P. 14.
Kim A.J., Barberio A., Berens P. et al. The trend, feasibility, and safety of salpingectomy as a form of permanent sterilization // J. Minim. Invasive Gynecol. 2019. Vol. 26. N. 7. P. 1363.
Kjos S.L., Peters R.K., Xiang A. et al // Contraception. and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus // JAMA 1998. Vol. 280. P. 533.
Kluft C., Meijer P., LaGuardia K.D. et al. Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables // Contraception. 2008. Vol. 77. N. 2. P. 77.
Kohler T.S., Fazili A.A., Brannigan R.E. Putative health risks associated with vasectomy // Urol. Clin. North. Am. 2009. Vol. 36. N. 3. P. 337.
Kulier R., Boulvain M., Walker D. et al. Minilaparotomy and endoscopic techniques for tubal sterilization // Cochrane Database Syst. Rev. 2004. N. 3. P. CD001328.
Laumonerie P., Blasco L., Tibbo M.E. et al. Peripheral nerve injury associated with a subdermal contraceptive implant: illustrative cases and systematic review of literature // World Neurosurg. 2018. Vol. 111. P. 317.
Lathrop E., Haddad L., McWhorter C.P. Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial // Contraception. 2013. Vol. 88. N. 6. P. 725.
Aghajanian A., Bernstein L., Grimes D.A. Bartholin’s duct abscess and cyst: a case-control study // South Med. J. 1994. Vol. 87. N. 1. P. 26.
Alhusayen R., Shear N.H. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?// Am. J. Clin. Dermatol. 2012. Vol. 13. N. 5. P. 283.
American College of Obstetricians and Gynecologists: Diagnosis and management of vulvar skin disorders // Practice Bulletin. N. 93, May 2008, Reaffirmed 2016.
American College of Obstetricians and Gynecologists: Persistent vulvar pain // Committee Opinion. N. 673, September 2016.
Anderson M., Kutzner S., Kaufman R.H. Treatment of vulvovaginal lichen planus with vaginal hydrocortisone suppositories // Obstet. Gynecol. 2002. N. 100. N. 2. P. 359.
Andreani S.M., Ratnasingham K., Dang H.H. et al. Crohn’s disease of the vulva // Int. J. Surg. 8. N. 1. P. 2, 2010.
Arnold L.D., Bachmann G.A., Rosen R. et al. Vulvodynia: characteristics and associations with comorbidities and quality of life // Obstet. Gynecol. 2006. Vol. 107. N. 3. P. 617.
Bachmann G.A., Brown C.S., Phillips N.A. et al. Gabapentin Study Group. Effect of gabapentin on sexual function in vulvodynia: a randomized, placebo-controlled trial // Am. J. Obstet. Gynecol. 2019. Vol. 220. N. 1. P. 89.e1.
Bacigalupi R.M., Postolova A., Davis R.S. Evidence-based, non-surgical treatments for vitiligo: a review // Am. J. Clin. Dermatol. 2012. Vol. 13. N. 4. P. 217.
Baggish M.S., Sze E.H., Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome // Am. J. Obstet. Gynecol. 1997. Vol. 177. N. 3. P. 507.
Barret M., de Parades V., Battistella M. et al. Crohn’s disease of the vulva // J. Crohns. Colitis. 8. N. 7. P. 563, 2014.
Barth J.H., Layton A.M., Cunliffe W.J. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa // Br. J. Dermatol. 1996. Vol. 134. N. 6. P. 1057.
Bergeron S., Binik Y.M., Khalife S. et al. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria // Obstet. Gynecol. 2001. Vol. 98. N. 1. P. 45.
Bergeron S., Brown C., Lord M.J. et al. Physical therapy for vulvar vestibulitis syndrome: a retrospective study // J. Sex. Marital. Ther. 2002. Vol. 28. N. 3. P. 183.
Bertolasi L., Frasson E., Cappelletti J.Y. et al. Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome // Obstet. Gynecol. 2009. Vol. 114. N. 5. P. 1008.
Boardman L.A., Cooper A.S., Blais L.R. et al. Topical gabapentin in the treatment of localized and generalized vulvodynia // Obstet. Gynecol. 2008. Vol. 112. N. 3. P. 579.
Bohm M., Luger T., Metie D. Treatment of mixed-type acanthosis nigricans with topical calcipotriol // Br. J. Derm. 1998. Vol. 139. N. 5. P. 932.
Boissy R.E., Nordlund J.J. Molecular basis of congenital hypopigmentary disorders in humans: a review // Pigment. Cell Res. 1997. Vol. 10. N. 1-2. P. 12.
Bor S., Feiwel M., Chanarin I. Vitiligo and its aetiological relationship to organ-specific autoimmune disease // Br. J. Derm. 1969. Vol. 81. N. 2. P. 83.
Bornstein J., Goldstein A.T., Stockdale C.K. et al. 2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia // Obstet. Gynecol. 2016. Vol. 127. N. 4. P. 745.
Bornstein J., Heifetz S., Kellner Y. et al. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus // Am. J. Obstet. Gynecol. 1998. Vol. 178. N. 1 Pt 1. P. 80.
Bornstein J., Zarfati D., Goldik Z. et al. Vulvar vestibulitis: physical or psychosexual problem? // Obstet. Gynecol. 1999. Vol. 93. N. 5 Pt 2. P. 876.
Bowen A.R., Vester A., Marsden L. et al. The role of vulvar skin biopsy in the evaluation of chronic vulvar pain // Am. J. Obstet. Gynecol. 2008. Vol. 199. N. 5. P. 467.e1.
Bradford J., Fischer G. Desquamative inflammatory vaginitis: differential diagnosis and alternate diagnostic criteria // J. Low. Genit. Tract. Dis. 2010. Vol. 14. N. 4. P. 306.
Bradford J., Fischer G. Management of vulvovaginal lichen planus: a new approach // J. Low Genit. Tract. Dis. 2013. Vol. 17. N. 1. P. 28.
Brown C.S., Bachmann G.A., Wan J. et al. Gabapentin for the treatment of vulvodynia: a randomized controlled trial // Obstet. Gynecol. 2018. Vol. 131. N. 6. P. 1000.
Brun J., Youbi A., Hocke C. Complications, sequelae and outcome of cervical conizations: evaluation of three surgical technics // J. Gynecol. Obstet. Bio. Reprod. 2002. Vol. 31. N. 6. P. 558.
Cooper S.M., Wojnarowska F. Influence of treatment of erosive lichen planus of the vulva on its prognosis // Arch. Dermatol. 2006. Vol. 142. N. 3. P. 289.
Demir S., Demir Y. Acrochordon and impaired carbohydrate metabolism // Acta. Diabetol. 2002. Vol. 39. N. 2. P. 57.
der Werth J.M., Williams H.C. The natural history of hidradenitis suppurativa // J. Eur. Acad. Dermatol. Venereol. 2000. Vol. 14. N. 5. P. 389.
Donder G. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis // BJOG 2002. Vol. 109. P. 1.
Edwards L. Pigmented vulvar lesions // Dermatol. Ther. 2010. Vol. 23. N. 5. P. 449.
Edwards L., Friedrich E.G. Jr. Desquamative vaginitis: lichen planus in disguise // Obstet. Gynecol. 1988. Vol. 71. N. 6 Pt 1. P. 832.
Eisen D. The therapy of oral lichen planus // Crit. Rev. Oral. Biol. Med. 1993. Vol. 4. N. 2. P. 141.
Eva L.J., MacLean A.B., Reid W.M. et al. Estrogen receptor expression in vulvar vestibulitis syndrome // Am. J. Obstet. Gynecol. 2003. Vol. 189. N. 2. P. 458.
Farage M., Maibach H.I. The vulvar epithelium differs from the skin: implications for cutaneous testing to address topical vulvar exposures // Contact. Dermatitis. 2004. Vol. 51. N. 4. P. 201.
Fischer G.O. The commonest causes of symptomatic vulvar disease: a dermatologist’s perspective // Australas. J. Dermatol. 1996. Vol. 37. N. 1. P. 12.
Food and Drug Administration: Tacrolimus. N. marketed as Protopic Ointment) Information, 2015.
Frieling U., Bonsmann G., Schwarz T. et al. Treatment of severe lichen planus with mycophenolate mofetil // J. Am. Acad. Dermatol. 2003. Vol. 49. P. 1063.
Funaro D. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus // J. Am. Acad. Dermatol. 2014. Vol. 71. N. 1. P. 84.
Gelfand J.M., Stern R.S., Nijsten T. The prevalence of psoriasis in African Americans: results from a population-based study // J. Am. Acad. Dermatol. 2005. Vol. 52. N. 1. P. 23.
Gener G., Canoui-Poitrine F., Revuz J.E. et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients // Dermatology. 2009. Vol. 219. N. 2. P. 148.
Goldstein A.T., Burrows L.J. Surgical treatment of clitoral phimosis caused by lichen sclerosus // Am. J. Obstet. Gynecol. 2007. Vol. 196. N. 2. P. 126.e1.
Goldstein A.T., Creasey A., Pfau R. et al. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus // J. Am. Acad. Dermatol. 2011. Vol. 64. N. 6. P. e99.
Goldstein A.T., Marinoff S.C., Christopher K. et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice // J. Reprod. Med. 2005. Vol. 50. P. 477.
Goldstein A.T., Metz A. Vulvar lichen planus // Clin. Obstet. Gynecol. 2005. P. 48. N. 4. P. 818.
Griffiths C.E., Clark C.M., Chalmers R.J. et al. A systematic review of treatments for severe psoriasis // Health Technol. Assess. 2000. Vol. 4. N. 40. P. 1.
Grimes P.E. New insights and new therapies in vitiligo // JAMA 2005. Vol. 293. N. 6. P. 730.
Guerrero A., Vankatesan A. Inflammatory vulvar dermatoses // Clin. Obstet. Gynecol. 2015. Vol. 58. P. 464.
Haefner H.K., Collins M.E., Davis G.D. et al. The vulvodynia guideline // J. Low Genit. Tract. Dis. 2005. Vol. 9. N. 1. P. 40.
Harlow B.L., Abenhaim H.A., Vitonis A.F. et al. Influence of dietary oxalates on the risk of adult-onset vulvodynia // J. Reprod. Med. 2008. Vol. 53. N. 3. P. 171.
Harlow B.L., Kunitz C.G., Nguyen R.H. et al. Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions // Am. J. Obstet. Gynecol. 2014. Vol. 210. N. 1. P. 40.e1.
Harlow B.L., Stewart E.G. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? // J. Am. Med. Womens Assoc. 200. Vol. 58. N. 2. P. 82.
Harris G., Horowitz B., Borgida A. Evaluation of gabapentin in the treatment of generalized vulvodynia, unprovoked // J. Reprod. Med. 2007. Vol. 52. N. 2. P. 103.
Heller D. Pigmented vulvar lesions — a pathology review of lesions that are not melanoma // J. Low Genit. Tract. Dis. 2013. Vol. 17. N. 3. P. 320.
Heller D.S., Bean S. Lesions of the Bartholin gland: a review // J. Low Genit. Tract. Dis. 2014. Vol. 18. N. 4. P. 351.
Hengge U.R., Krause W., Hofmann H. et al. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus // Br. J. Dermatol. 2006. Vol. 155. N. 5. P. 1021.
Herbst A.L., Ulfelder H., Poskanzer D.C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women // N. Engl. J. Med. 1971. Vol. 284. N. 15. P. 878.
Hermanns-Le T., Scheen A., Pierard G.E. Acanthosis nigricans associated with insulin resistance: pathophysiology and management // Am. J. Clin. Dermatol. 2004. Vol. 5. N. 3. P. 199.
Hillemanns P., Untch M., Prove F. et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid // Obstet. Gynecol. 1999. Vol. 93. N. 1. P. 71.
Hu J., Haefner H.K. The management of vacuum-assisted closure following vulvectomy with skin grafting // Plast. Reconstr. Surg. Glob. Open. 2018. Vol. 6. N. 4. P. e1726.
Hurley H.J. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus: surgical approach / Roenigk R.K., Roenigk H.H. Dermatologic Surgery. New York: Marcel Dekker, 1989. 729 p.
Janniger C.K., Schwartz R.A., Szepietowski J.C. et al. Intertrigo and common secondary skin infections // Am. Fam. Physician. 2005. Vol. 72. N. 5. P. 833.
Kahana M., Levy A., Schewach-Millet M. et al. Appearance of lupus erythematosus in a patient with lichen sclerosus et atrophicus of the elbows // J. Am. Acad. Dermatol. 1985. Vol. 12. N. 1 Pt 1. P. 127.
Kaufman R.H., Faro S., Brown D. Benign Diseases of the Vulva and Vagina. Philadelphia: Mosby, 2005.
Kaufman R.H., Gardner H.L., Brown D. Jr. et al. Vulvar dystrophies: an evaluation // Am. J. Obstet. Gynecol. 1974. Vol. 120. N. 3. P. 363.
Kessous R., Aricha-Tamir B., Sheizaf B. et al. Clinical and microbiological characteristics of Bartholin gland abscesses // Obstet. Gynecol. 2013. Vol. 122. N. 4. P. 794.
Ko C.J. Keratoacanthoma: facts and controversies // Clin. Dermatol. 2010. Vol. 28. N. 3. P. 254.
Laftah Z., Bailey C., Zaheri S. et al. Vulval Crohn’s disease: a clinical study of 22 patients // J. Crohns. Colitis. 2015. Vol. 9. N. 4. P. 318.
Landry T., Bergeron S., Dupuis M.J. et al. The treatment of provoked vestibulodynia // Clin. J. Pain. 2008. Vol. 24. P. 155.
Lavy R.J., Hynan L.S., Haley R.W. Prevalence of vulvar pain in an urban, minority population // J. Reprod. Med. 2007. Vol. 52. P. 59.
Lee A., Bradford J., Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women // JAMA Dermatol. 2015. Vol. 151. P. 1061.
Lee A., Lim A., Fischer G. Fractional carbon dioxide laser in recalcitrant vulval lichen sclerosus // Australas. J. Dermatol. 2016. Vol. 57. N. 1. P. 39.
Leung D.Y., Boguniewicz M., Howell M.D. et al. New insights into atopic dermatitis // J. Clin. Invest. 2004. Vol. 113. N. 5. P. 651.
Lundqvist E.N., Wahlin Y.B., Hofer P.A. Methotrexate supplemented with steroid ointments for the treatment of severe erosive lichen ruber // Acta. Derm. Venereol. 2002. Vol. 82. P. 63.
Lynch P.J. Lichen simplex chronicus. N. atopic/neurodermatitis) of the anogenital region // Dermatol. Ther. 2004. Vol. 17. N. 1. P. 8.
Lynch P.J., Moyal-Barracco M., Bogliatto F. et al. 2006 ISSVD classification of vulvar dermatoses: pathological subsets and their clinical correlates // J. Reprod. Med. 2007. Vol. 52. N. 1. P. 3.
Lynch P.J., Moyal-Barracco M., Scurry J. et al: 2011 ISSVD terminology and classification of vulvar dermatological disorders: an approach to clinical diagnosis // J. Reprod. Med. 2012. Vol. 16. N. 4. P. 339.
Mann M.S., Kaufman R.H. Erosive lichen planus of the vulva // Clin. Obstet. Gynecol. 1991. Vol. 34. N. 3. P. 605.
Margesson L.J. Contact dermatitis of the vulva // Dermatol Ther 2004. Vol. 17. N. 1. P. 20.
Marren P., Wojnarowska F., Powell S. Allergic contact dermatitis and vulvar dermatoses // Br. J. Dermatol. 1992. Vol. 126. N. 1. P. 52.
Mattila A., Miettinen A., Heinonen P.K. Microbiology of Bartholin’s duct abscess // Infect. Dis. Obstet. Gynecol. 1994. Vol. 1. N. 6. P. 265.
Mazdisnian F., Degregorio F., Mazdisnian F. et al. Intralesional injection of triamcinolone in the treatment of lichen sclerosus // J. Reprod. Med. 1999. Vol. 44. N. 4. P. 332.
Mirowski G.W., Edwards L. Diagnostic and therapeutic procedures / Edwards L. Genital Dermatology Atlas. Philadelphia: Lippincott Williams & Wilkins, 2004. 9 p.
Mistiaen P., Poot E., Hickox S. et al. Preventing and treating intertrigo in the large skin folds of adults: a literature overview // Dermatol. Nurs 2004. Vol. 16. N. 1. P. 43.
Morrissey D., El-Khawand D., Ginzburg N. et al. Botulinum toxin a injections into pelvic floor muscles under electromyographic guidance for women with refractory high-tone pelvic floor dysfunction: a 6-month prospective pilot study // Female Pelvic. Med. Reconstr. Surg. 2015. Vol. 21. N. 5. P. 277.
Mortimer P.S., Dawber R.P., Gales M.A. et al. Mediation of hidradenitis suppurativa by androgens // Br. Med. J. (Clin. Res. Ed.) 1986. Vol. 292. N. 6515. P. 245.
Moyal-Barracco M., Edwards L. Diagnosis and therapy of anogenital lichen planus // Dermatol. Ther. 2004. Vol. 17. N. 1. P. 38.
Murina F., Tassan P., Roberti P. et al. Treatment of vulvar vestibulitis with submucous infiltrations of methylprednisolone and lidocaine. An alternative approach // J. Reprod. Med. 2001. Vol. 46. N. 8. P. 713.
Nielsen G.P., Rosenberg A.E., Koerner F.C. et al. Smooth-muscle tumors of the vulva. A clinicopathological study of 25 cases and review of the literature // Am. J. Surg. Pathol. 1996. Vol. 20. N. 7. P. 779.
Pagano R. Vulvar vestibulitis syndrome: an often unrecognized cause of dyspareunia // Aust. N. Z. J. Obstet. Gynaecol. 1999. Vol. 39. N. 1. P. 79.
Patel N.U., Roach C., Alinia H. et al. Current treatment options for acanthosis nigricans // Clin. Cosmet. Investig. Dermatol. 2018. N. 11. P. 407.
Poskitt L., Wojnarowska F. Lichen sclerosus as a cutaneous manifestation of thyroid disease // J. Am. Acad. Dermatol. 1993. Vol. 28. N. 4. P. 665.
Powell J., Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem // J. Am. Acad. Dermatol. 2001. Vol. 44. N. 5. P. 803.
Reed B.D., Caron A.M., Gorenflo D.W. et al. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors // J. Low Genit. Tract. Dis. 2006. Vol. 10. N. 4. P. 245.
Reed B.D., Crawford S., Couper M. et al. Pain at the vulvar vestibule: a web-based survey // J. Low Genit. Tract. Dis. 2004. N. 8. P. 48.
Reed B.D., Haefner H.K., Sen A. et al. Vulvodynia incidence and remission rates among adult women // Obstet. Gynecol. 2008. Vol. 112. P. 231.
Reed B.D., Legocki L.J., Plegue M.A. et al. Factors associated with vulvodynia incidence // Obstet. Gynecol. 2014. Vol. 123. N. 2 Pt. 1. P. 225.
Rhode J.M., Burke W.M., Cederna P.S. et al. Outcomes of surgical management of stage III vulvar hidradenitis suppurativa // J. Reprod. Med. 2008. Vol. 53. P. 420.
Riis P.T., Boer J., Prens E. et al. Intralesional triamcinolone for flares of hidradenitis suppurativa: a case series // J. Am. Acad. Dermatol. 2016. Vol. 75. N. 6. P. 1151.
Rogers R.S. III. Complex aphthosis // Adv. Exp. Med. Biol. 2003. Vol. 528. P. 311.
Rogers R.S. III. Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders // Semin. Cutan. Med. Surg. 1997. Vol. 16. N. 4. P. 278.
Romo A., Benavides S. Treatment options in insulin resistance obesity-related acanthosis nigricans // Ann. Pharmacother. 2008. Vol. 42. N. 7. P. 1090.
Rouzier R., Haddad B., Deyrolle C. et al. Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus // Am. J. Obstet. Gynecol. 2002. Vol. 186. N. 1. P. 49.
Saraiya A., Al-Shoha A., Brodell R.T. Hyperinsulinemia associated with acanthosis nigricans, finger pebbles, acrochordons, and the sign of Leser-Tr?lat // Endocr. Pract. 2013. Vol. 19. N. 3. P. 522.
Savage J.A., Maize J.C. Sr. Keratoacanthoma clinical behavior: a systematic review // Am. J. Dermatopathol. 2014. Vol. 36. N. 5. P. 422.
Segal D., Tifheret H., Lazer S. Submucous infiltration of betamethasone and lidocaine in the treatment of vulvar vestibulitis // Eur. J. Obstet. Gynecol. Reprod. Biol. 2003. Vol. 107. N. 1. P. 105.
Sherrard J., Wilson J., Donders G. et al. 2018 European. N. IUSTI/WHO) International Union Against Sexually Transmitted Infections (IUSTI) World Health Organization (WHO) guideline on the management of vaginal discharge // Int. J. STD AIDS 2018. Vol. 29. N. 13. P. 1258.
Sideri M., Origoni M., Spinaci L. et al. Topical testosterone in the treatment of vulvar lichen sclerosus // Int. J. Gynaecol. Obstet. 1994. Vol. 46. N. 1. P. 53.
Sides C., Trinidad M.C., Heitlinger L. et al. Crohn disease and the gynecologic patient // Obstet. Gynecol. Surv. 2013. Vol. 68. N. 1. P. 51.
Smith C.H., Anstey A.V., Barker J.N. et al. British Association of Dermatologists’ guideline for biologic interventions for psoriasis 2009 // Br. J. Dermatol. 2009. Vol. 161. N. 5. P. 987.
Smith C.H., Barker J.N. Psoriasis and its management // BMJ 2006. Vol. 333. N. 7564. P. 380.
Sobel J.D., Reichman O. Diagnosis and treatment of desquamative inflammatory vaginitis // Am. J. Obstet. Gynecol. 2011. Vol. 117. N. 4. P. 850.
Solomons C.C., Melmed M.H., Heitler S.M. Calcium citrate for vulvar vestibulitis. A case report // J. Reprod. Med. 1991. Vol. 36. N. 12. P. 879.
Spergel J.M., Paller A.S. Atopic dermatitis and the atopic march // J. Allergy Clin. Immunol. 2003. Vol. 112. Suppl. 6. P. S118.
Steward K.M. Challenging ulcerative vulvar conditions: hidradenitis suppurativa, Crohn disease, and aphthous ulcers // Obstet. Gynecol. Clin. North Am. 2017. Vol. 44. N. 3. P. 453.
Stockdale C.K., Lawson H.W. 2013 Vulvodynia Guideline update // J. Low Genit. Tract. Dis. 2014. Vol. 18. N. 2. P. 93.
Tanaka K., Mikamo H., Ninomiya M. et al. Microbiology of Bartholin’s gland abscess in Japan // J. Clin. Microbiol. 2005. Vol. 43. N. 8. P. 4258.
Torgerson R.R., Marnach M.L., Bruce A.J. et al. Oral and vulvar changes in pregnancy // Clin. Dermatol. 2006. Vol. 24. N. 2. P. 122.
Traas M.A., Bekkers R.L., Dony J.M. et al. Surgical treatment for the vulvar vestibulitis syndrome // Obstet. Gynecol. 2006. Vol. 107. N. 2 Pt 1. P. 256.
Virgili A., Bacilieri S., Corazza M. Evaluation of contact sensitization in vulvar lichen simplex chronicus. A proposal for a battery of selected allergens // J. Reprod. Med. 2003. Vol. 48. N. 1. P. 33.
Visco A.G., Del Priore G. Postmenopausal Bartholin gland enlargement: a hospital-based cancer risk assessment // Obstet. Gynecol. 1996. Vol. 87. N. 2. P. 286.
Vrijman C., Kroon M.W., Limpens J. et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review // Br. J. Dermatol. 2012. Vol. 167. N. 6. P. 1224.
Zellis S., Pincus S.H. Treatment of vulvar dermatoses // Semin Dermatol 1996. Vol. 15. N. 1. P. 71.
Zendels K. Genital lichen planus: update on diagnosis and treatment // Seminar. Cutan. Med. Surg. 2015. Vol. 34. P. 182.
Zhang X.J., Chen J.J., Liu J.B. The genetic concept of vitiligo // J. Dermatol. Sci. 2005. Vol. 39. N. 3. P. 137.
Albert X., Huertas I., Pereir? I.I. et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women // Cochrane Database Syst. Rev. 2004. N. 3. P. CD001209.
American College of Obstetricians and Gynecologists: Treatment of urinary tract infections in nonpregnant women // Practice Bulletin. N. 91. March 2008. Reaffirmed 2016.
American College of Obstetricians and Gynecologists: Long-acting reversible contraception: implants and intrauterine devices // Practice Bulletin. N. 186. November 2017.
American College of Obstetricians and Gynecologists: Vaginitis // Practice Bulletin. N. 72. May 2006. Reaffirmed 2017.
American College of Obstetricians and Gynecologists: Prevention of infection after gynecologic procedures // Practice Bulletin. N. 195. June 2014. Reaffirmed 2018.
American College of Obstetricians and Gynecologists: Routine human immunodeficiency virus screening // Committee Opinion. N. 596. May 2014. Reaffirmed 2019.
American College of Radiology: ACR–SIR–SPR practice parameter for specifications and performance of image-guided percutaneous drainage/aspiration of abscesses and fluid collections // Resolution. N. 13. 2018.
Amsel R., Totten P.A., Spiegel C.A. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations // Am. J. Med. 1983. Vol. 74. P. 14.
Anderson M.R., Klink K., Kohrssen A. Evaluation of vaginal complaints // JAMA 2004. Vol. 291. P. 1368.
Ashley-Morrow R., Krantz E., Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2 // Sex. Transm. Dis. 2003. Vol. 30. N. 4. P. 310.
Atashili J., Poole C., Ndumbe P.M. et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies // AIDS 2008. Vol. 22. N. 12. P. 1493.
Ayeleke R.O., Mourad S., Marjoribanks J. et al. Antibiotic prophylaxis for elective hysterectomy // Cochrane Database Syst. Rev. 2017. N. 6. P. CD004637.
Baczynska A., Funch P., Fedder J. et al. Morphology of human Fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominis — in vitro organ culture study // Hum. Reprod. 2007. Vol. 22. N. 4. P. 968.
Ballard D.H., Raptis C.A., Guerra J. et al. Preoperative CT findings and interobserver reliability of Fournier gangrene // AJR 2018. Vol. 211. N. 5. P. 1051.
Baker D.A., Ferris D.G., Martens M.G. et al. Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies // Infect. Dis. Obstet. Gynecol. 2011. Vol. 2011. P. 806105.
Ban K.A., Minei J.P., Laronga C. et al. American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update // J. Am. Coll. Surg. 2017. Vol. 224. N. 1. P. 59.
Bartlett J.G., Onderdonk A.B., Drude E. et al. Quantitative bacteriology of the vaginal flora // J. Infect. Dis. 1977. Vol. 136. N. 2. P. 271.
Beerepoot M., Geerlings S. Non-antibiotic prophylaxis for urinary tract infections // Pathogens. 2016. Vol. 5. N. 2. P. E36.
Belshe R.B., Leone P.A., Bernstein D.I. et al. Efficacy results of a trial of a herpes simplex vaccine // N. Engl. J. Med. 2012. Vol. 366. N. 1. P. 34.
Bent S., Nallamothu B.K., Simel D.L. et al. Does this woman have an acute uncomplicated urinary tract infection? // JAMA 2002. Vol. 287. N. 20. P. 2701.
Bernstein D.I., Bellamy A.R., Hook E.W. et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women // Clin. Infect. Dis. 2013. Vol. 56. N. 3. P. 344.
Beutner K.R., Reitano M.V., Richwald G.A. et al. External genital warts: report of the American Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts // Clin. Infect. Dis. 1998. N. 27. P. 796.
Birnbaum D.M. Microscopic findings / Knoop K.J., Stack L.B., Storrow A.B. Atlas of Emergency Medicine. New York: McGraw-Hill, 2010.
Bleker O.P., Smalbraak D.J., Schutte M.F. Bartholin’s abscess: the role of Chlamydia trachomatis // Genitourin. Med. 1990. Vol. 66. P. 24.
Boskey E.R., Cone R.A., Whaley K.J. et al. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source // Hum. Reprod. 2001. N. 16. N. 9. P. 1809.
Bradley H., Markowitz L.E., Gibson T. et al. Seroprevalence of herpes simplex virus types 1 and 2—United States, 1999–2010 // J. Infect. Dis. 2014. Vol. 209. N. 3. P. 325.
Bradshaw C.S., Morton A.N., Garland S.M. et al. Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis // Obstet. Gynecol. 2005. Vol. 106. P. 105.
Bradshaw C.S., Morton A.N., Hocking J. et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence // J. Infect. Dis. 2006. Vol. 193. P. 1478.
Brotman R.M., Klebanoff M.A., Nansel T.R. et al. A longitudinal study of vaginal douching and bacterial vaginosis—a marginal structural modeling analysis // Am. J. Epidemiol. 2008. Vol. 168. N. 2. P. 188.
Bruggemann R., Alffenaar J., Blijlevens N. et al. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents // Clin. Inf. Dis. 2009. Vol. 48. N. 10. P. 1441.
Burnett A.M., Anderson C.P., Zwank M.D: Laboratory-confirmed gonorrhea and/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis // Am. J. Emerg. Med. 2012. Vol. 30. N. 7. P. 1114.
Centers for Disease Control and Prevention: Expedited partner therapy in the management of sexually transmitted diseases. Atlanta, U.S.: Department of Health and Human Services, 2006.
Centers for Disease Control and Prevention: Discordant results from reverse sequence syphilis screening?five laboratories, United States, 2006–2010 // MMWR 2011. Vol. 60. N. 5. P. 133.
Centers for Disease Control and Prevention: Procedure-associated module: surgical site infection (SSI) event. 2014.
Centers for Disease Control and Prevention: Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae–2014 // MMWR 2014. Vol. 63. N. 2. P. 1.
Centers for Disease Control and Prevention, Association of Public Health Laboratories: Laboratory testing for the diagnosis of HIV infection: updated recommendations. 2014.
Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, 2015 // MMWR 2015. Vol. 59. N. 12. P. 1.
Centers for Disease Control and Prevention: Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV — United States, 2016. 2016.
Centers for Disease Control and Prevention: Technical update: use of the determine HIV 1/2 Ag/Ab combo test with serum or plasma in the laboratory algorithm for HIV diagnosis. 2017.
Centers for Disease Control and Prevention: Sexually transmitted disease surveillance, 2017. Atlanta, U.S.: Department of Health and Human Services, 2018.
Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline. 2018.
Centers for Disease Control and Prevention: Surgical site infection(SSI) event. 2019.
Ceovic R., Gulin S.J. Lymphogranuloma venereum: diagnostic and treatment challenges // Infect. Drug. Resist. 2015. N. 8. P. 39.
Cohen M.S., Chen Y.Q., McCauley M. et al. Antiretroviral therapy for the prevention of HIV-1 transmission // N. Engl. J. Med. 2016. Vol. 375. N. 9. P. 830.
Coleman J.S., Gaydos C.A. Molecular diagnosis of bacterial vaginosis: an update // J. Clin. Microbiol. 2018. Vol. 56. N. 9. P. e00342.
Copeland N.K., Decker C.F. Other sexually transmitted diseases chancroid and donovanosis // Dis. Mon. 2016. Vol. 62. N. 8. P. 306.
Corey L., Wald A., Patel R. et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes // N. Engl. J. Med. 2004. Vol. 350. P. 11.
Curtis E.M., Pine L. Actinomyces in the vaginas of women with and without intrauterine contraceptive devices // Am. J. Obstet. Gynecol. 1981. Vol. 140. P. 880.
Czaja C.A., Scholes D., Hooton T.M. et al. Population-based epidemiologic analysis of acute pyelonephritis // Clin. Infect. Dis. 2007. Vol. 45. N. 3. P. 273.
Dahn A., Saunders S., Hammond J.A. et al. Effect of bacterial vaginosis, Lactobacillus and Premarin estrogen replacement therapy on vaginal gene expression changes // Microbes. Infect. 2008. Vol. 10. N. 6. P. 620.
Daley G., Russell D., Tabrizi S. et al. Mycoplasma genitalium: a review // Int. J. STD AIDS 2014. Vol. 25. N. 7. P. 475.
Devilla W.L., Yzermans J.C., van Duijn N.P. et al. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy // BMC Urol. 2004. N. 4. P. 4.
Dewitt J., Reining A., Allsworth J.E. et al. Tuboovarian abscesses: is size associated with duration of hospitalization & complications? // Obstet. Gynecol. Int. 2010. P. 847041.
Donders G.G., Sobel J.D. Candida vulvovaginitis: a store with a buttery and a show window // Mycoses. 2017. Vol. 60. N. 2. P. 70.
Dunbar-Jacob J., Sereika S.M., Foley S.M. et al. Adherence to oral therapies in pelvic inflammatory disease // J. Womens Health 2004. N. 13. P. 285.
Echols R.M., Tosiello R.L., Haverstock D.C. et al. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis // Clin. Infect. Dis. 1999. Vol. 29. N. 1. P. 113.
Fan H., Wang T.T., Ren G. et al. Characterization of tubo-ovarian abscess mimicking adnexal masses: comparison between contrast-enhanced CT. N. 18)F-FDG PET/CT and MRI // Taiwan J. Obstet. Gynecol. 2018. Vol. 57. N. 1. P. 40.
Fanfair R.N., Zaidi A., Taylor L.D. et al. Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years — United States, 1988 to 2010 // Sex. Transm. Dis. 2013. Vol. 40. N. 11. P. 860.
Fethers K.A., Fairley C.K., Hocking J.S. et al. Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis // Clin. Infect. Dis. 2008. Vol. 47. N. 11. P. 1426.
Fettweis J.M., Brooks J.P., Serrano M.G. et al. Differences in vaginal microbiome in African American women versus women of European ancestry // Microbiology. 2014. Vol. 160. N. Pt. 10. P. 2272.
Fiorino A.S. Intrauterine contraceptive device-associated actinomycotic abscess and Actinomyces detection on cervical smear // Obstet. Gynecol. 1996. Vol. 87. P. 142.
Flagg E.W., Torrone E.A. Declines in anogenital warts among age groups most likely to be impacted by human papillomavirus vaccination, United States, 2006–2014 // Am. J. Public Health. 2018. Vol. 108. N. 1. P. 112.
Food and Drug Administration: FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. 2018.
Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis // N. Engl. J. Med. 2005. Vol. 353. P. 1899.
Gardner H.L., Dukes C.D. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis // Am. J. Obstet. Gynecol. 1955. Vol. 69. P. 962.
Garland S.M., Steben M., Sings H.L. et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of quadrivalent human papillomavirus. N. types 6, 11, 16, and 18) vaccine // J. Infect. Dis. 2009. Vol. 199. N. 6. P. 805.
Gaydos C.A., Beqaj S., Schwebke JR. et al. Clinical validation of a test for the diagnosis of vaginitis // Obstet. Gynecol. 130. N. 1. P. 181, 2017a.
Gaydos CA, Schwebke J, Dombrowski J. et al. Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women // Expert. Rev. Mol. Diagn. 2017. Vol. 17. N. 3. P. 303.
Getman D., Jiang A., O’Donnell M. et al. Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States // J. Clin. Microbiol. 2016. Vol. 54. N. 9. P. 2278.
Gjelland K., Ekerhovd E., Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases // Am. J. Obstet. Gynecol. 2005. Vol. 193. P. 1323.
Goh T., Goh L.G., Ang C.H. et al. Early diagnosis of necrotizing fasciitis // Br. J. Surg. 2014. Vol. 101. N. 1. P. e119.
Goller J.L., De Livera A.M., Fairley C.K. et al. Characteristics of pelvic inflammatory disease where no sexually transmitted infection is identified: a cross-sectional analysis of routinely collected sexual health clinic data // Sex. Transm. Infect. 2017. Vol. 93. N. 1. P. 68.
Gupta K., Chou M.Y., Howell A. et al. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells // J. Urol. 2007. Vol. 177. N. 6. P. 2357.
Gupta K., Grigoryan L., Trautner B. Urinary tract infection // Ann. Intern. Med. 2017. Vol. 167. N. 7. P. ITC49.
Gupta K., Hooton T.M., Naber K.G. et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases // Clin. Infect. Dis. 2011. Vol. 52. N. 5. P. e103.
Hadgu A., Westrom L., Brooks C.A. et al. Predicting acute pelvic inflammatory disease: a multivariate analysis // Am. J. Obstet. Gynecol. 1986. Vol. 155. P. 954.
Hansfield H.H. Vaginal infections. In Color Atlas and Synopsis of Sexually Transmitted Diseases. New York: McGraw-Hill, 2001. 169 p.
Hazenberg M.D., Hamann D., Schuitemaker H. et al. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock // Nat. Immunol. 2000. Vol. 1. N. 4. P. 285.
Helms D.J., Mosure D.J., Secor W.E. et al. Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity // Am. J. Obstet. Gynecol. 2008. Vol. 198. N. 4. P. 370 e371.
Hemsell D.L., Obregon V.L., Heard M.C. et al. Endometrial bacteria in asymptomatic, nonpregnant women // J. Reprod. Med. 1989. N. 34. P. 872.
Hiller N., Fux T., Finkelstein A. et al. CT differentiation between tubo-ovarian and appendiceal origin of right lower quadrant abscess: CT, clinical, and laboratory correlation // Emerg. Radiol. 2016. Vol. 23. N. 2. P. 133.
Hillier S.L., Nugent R.P., Eschenbach D.A. et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group // N. Engl. J. Med. 1995. Vol. 333. P. 1737.
Hobbs M.M., Se?a A.C. Modern diagnosis of Trichomonas vaginalis infection // Sex. Transm. Infect. 2013. Vol. 89. N. 6. P. 434.
Holmes N.E., Howden B.P. What’s new in the treatment of serious MRSA infection?// Curr. Opin. Infect. Dis. 2014. Vol. 27. N. 6. P. 471.
Hooton T.M., Roberts P.L., Cox M.E. et al. Voided midstream urine culture and acute cystitis in premenopausal women // N. Engl. J. Med. 2013. Vol. 369. N. 20. P. 1883.
Hooton T.M., Stamm W.E. Diagnosis and treatment of uncomplicated urinary tract infection // Infect. Dis. Clin. North. Am. 1997. N. 11. P. 551.
Hooton T.M., Vecchio M., Iroz A. et al. Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections: a randomized clinical trial // JAMA Intern. Med. 2018. Vol. 178. N. 11. P. 1509.
Howe K., Kissinger P.J. Single-dose compared with multidose metronidazole for the treatment of trichomoniasis in women: a meta-analysis // Sex. Transm. Dis. 2017. Vol. 44. N. 1. P. 29.
Huppert J.S., Batteiger B.E., Braslins P. et al. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens // J. Clin. Microbiol. 43:684, 2005.
Huppert JS, Mortensen JE, Reed JL. et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women // Clin. Infect. Dis. 2007. Vol. 45. N. 2. P. 194.
Jensen J.S., Cusini M., Gomberg M. et al. 2016 European guideline on Mycoplasma genitalium infections // J. Eur. Acad. Dermatol. Venereol. 2016. Vol. 30. N. 10. P. 1650.
Jepson R.G., Williams G., Craig J.C. Cranberries for preventing urinary tract infections // Cochrane Database Syst. Rev. 2012. N. 10. P. CD001321.
Joesoef M.R., Westrom L., Reynolds G. et al. Recurrence of ectopic pregnancy: the role of salpingitis // Am. J. Obstet. Gynecol. 1991. Vol. 165. P. 46.
Jung S.I., Kim Y.J., Park H.S. et al. Acute pelvic inflammatory disease: diagnostic performance of CT // J. Obstet. Gynaecol. Res. 2011. Vol. 37. N. 3. P. 228.
Kang C., Kim K., Lee S.H. et al. A risk stratification model of acute pyelonephritis to indicate hospital admission from the ED // Am. J. Emerg. Med. 2013. Vol. 31. N. 7. P. 1067.
Keane F.E., Ison C.A., Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle // Int. J. STD AIDS 1997. N. 8. P. 489.
Kessous R., Aricha-Tamir B., Sheizaf B. et al. Clinical and microbiological characteristics of Bartholin gland abscesses // Obstet. Gynecol. 2013. Vol. 122. N. 4. P. 794.
Kilpatrick C.C., Alagkiozidis I., Orejuela F.J. et al. Factors complicating surgical management of vulvar abscess // J. Reprod. Med. 2010. Vol. 55. N. 3–4. P. 139.
Kim J.Y., Kim Y , Jeong W.K. et al. Perihepatitis with pelvic inflammatory disease. N. PID) on MDCT: characteristic findings and relevance to PID // Abdom. Imaging. 2009. Vol. 34. N. 6. P. 737.
Kingston M.A., Bansal D., Carlin E.M. ‘Shelf life’ of Trichomonas vaginalis // Int. J. STD AIDS 2003. Vol. 14. N. 1. P. 28.
Kirby J.P., Mazuski J.E. Prevention of surgical site infection // Surg. Clin. North Am. 2009. Vol. 89. N. 2. P. 365.
Klebanoff M.A., Nansel T.R., Brotman R.M. et al. Personal hygienic behaviors and bacterial vaginosis // Sex. Transm. Dis. 2010. Vol. 37. N. 2. P. 94.
Komericki P., Akkilic-Materna M., Strimitzer T. et al. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts // Sex. Transm. Dis. 2011. Vol. 38. N. 3. P. 216.
Kreisel K., Torrone E., Bernstein K. et al. Prevalence of pelvic inflammatory disease in sexually experienced women of reproductive age — United States, 2013–2014 // MMWR 2017. Vol. 66. N. 3. P. 80.
Krissi H., Shmuely A., Aviram A. et al. Acute Bartholin’s abscess: microbial spectrum, patient characteristics, clinical manifestation, and surgical outcomes // Eur. J. Clin. Microbiol. Infect. Dis. 2016. Vol. 35. N. 3. P. 443.
Kroese J.A., van der Velde M., Morssink L.P. et al. Word catheter and marsupialisation in women with a cyst or abscess of the Bartholin gland (WoMan-trial) a randomised clinical trial // BJOG 2017. Vol. 124. N. 2. P. 243.
Kuhar D.T., Henderson D.K., Struble K.A. et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis // Infect. Control. Hosp. Epidemiol. 2013. Vol. 34. N. 9. P. 875.
Lachiewicz M.P., Moulton L.J., Jaiyeoba O. Pelvic surgical site infections in gynecologic surgery // Infect. Dis. Obstet. Gynecol. 2015. P. 614950.
Laga M., Manoka A., Kivuvu M. et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study // AIDS 1993. Vol. 7. N. 1. P. 95.
Lake A.G., McPencow A.M., Dick-Biascoechea M.A. et al. Surgical site infection after hysterectomy // Am. J. Obstet. Gynecol. 2013. Vol. 209. N. 5. P. 490.e1.
Landers D.V., Sweet R.L. Tubo-ovarian abscess: contemporary approach to management // Rev. Infect. Dis. 1983. Vol. 5. N. 5. P. 876.
Landers D.V., Wiesenfeld H.C., Heine R.P. et al. Predictive value of the clinical diagnosis of lower genital tract infection in women // Am. J. Obstet. Gynecol. 2004. Vol. 190. P. 1004.
Larsen S.A., Steiner B.M., Rudolph A.H. Laboratory diagnosis and interpretation of tests for syphilis // Clin. Microbiol. Rev. 1995. N. 8. P. 1.
Larsson P.G., Bergman B., F?rsum U. et al. Mobiluncus and clue cells as predictors of pelvic inflammatory disease after first trimester abortion // Acta. Obstet. Gynecol. Scand. 1989. Vol. 68. P. 217.
Larsson P.G., Platz-Christensen J.J., F?rsum U. et al. Clue cells in predicting infections after abdominal hysterectomy // Obstet. Gynecol. 1991. Vol. 77. P. 450.
Larsson P.G., Platz-Christensen J.J., Thejls H. et al. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study // Am. J. Obstet. Gynecol. 1992. Vol. 166. P. 100.
Lee W., Kim Y., Chang S. et al. The influence of vitamin C on the urine dipstick tests in the clinical specimens: a multicenter study // J. Clin. Lab. Anal. 2017. N. 31. P. 5.
LeFoff J., Pere H., Belec L. Diagnosis of genital herpes simplex virus infection in the clinical laboratory // Virol. J. 2014. N. 11. P. 83.
Leichliter J.S., Chandra A., Aral S.O. Correlates of self-reported pelvic inflammatory disease treatment in sexually experienced reproductive aged women in the United States, 1995 and 2006–2010 // Sex. Transm. Dis. 2013. Vol. 40. N. 5. P. 413.
Lillis R.A., Nsuami M.J., Myers L. et al. Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women // J. Clin. Microbiol. 2011. Vol. 49. N. 5. P. 1990.
Lippes J. Pelvic actinomycosis: a review and preliminary look at prevalence // Am. J. Obstet. Gynecol. 1999. Vol. 180. P. 265.
Liu C., Bayer A., Cosgrove S.E. et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary // Clin. Infect. Dis. 2011. Vol. 52. N. 3. P. 285.
Lis R., Rowhani-Rahbar A., Manhart L.E. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis // Clin. Inf. Dis. 2015. Vol. 61. N. 3. P. 418.
Llata E., Braxton J., Asbel L. et al. Rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among women reporting anal intercourse // Obstet. Gynecol. 2018. Vol. 132. N. 3. P. 692.
Lowe N.K., Neal J.L., Ryan-Wenger N.A. Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard // Obstet. Gynecol. 2009. Vol. 113. N. 1. P. 89.
Mahdi H., Goodrich S., Lockhart D. et al. Predictors of surgical site infection in women undergoing hysterectomy for benign gynecologic disease: a multicenter analysis using the national surgical quality improvement program data // J. Minim. Invasive Gynecol. 2014. Vol. 21. N. 5. P. 901.
Mangram A.J., Horan T.C., Pearson M.L. et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee // Infect. Control. Hosp. Epidemiol. 1999. Vol. 20. N. 4. P. 250.
Manhart L.E., Jensen J.S., Bradshaw C.S. et al. Efficacy of antimicrobial therapy for Mycoplasma genitalium infections // Clin. Infect. Dis. 2015. N. 61. Suppl. 8. P. S802.
Marques A.G., Doi A.M., Pasternak J. et al. Performance of the dipstick screening test as a predictor of negative urine culture // Einstein. (Sao Paulo) 2017. Vol. 15. N. 1. P. 34.
Martin E.T., Krantz E., Gottlieb S.L. et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition // Arch. Intern. Med. 2009. Vol. 169. N. 13. P. 1233.
Massad L.S., Xie X., Darragh T. et al. Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection // Obstet. Gynecol. 2011. Vol. 118. P. 831.
McClelland R.S., Sangare L., Hassan W.M. et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition // J. Infect. Dis. 2007. Vol. 195. N. 5. P. 698.
Meites E., Gaydos C.A., Hobbs M.M. et al. A review of evidence-based care of symptomatic trichomoniasis and asymptomatic Trichomonas vaginalis Infections // Clin. Infect. Dis. 2015. Vol. 61. Suppl. 8. P. S837.
Meltzer S.M., Monk B.J., Tewari K.S. Green tea catechins for treatment of external genital warts // Am. J. Obstet. Gynecol. 2009. Vol. 200. N. 3. P. 233.e1.
Miller R.L., Gerster J.F., Owens M.L. et al. Imiquimod applied topically: a novel immune response modifier and new class of drug // Int. J. Immunopharmacol. 1999. Vol. 21. N. 1. P. 1.
Mody L., Juthani-Mehta M. Urinary tract infections in older women: a clinical review // JAMA 2014. Vol. 311. N. 8. P. 844.
Molander P., Sj?berg J., Paavonen J. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease // Ultrasound Obstet. Gynecol. 2001. N. 17. P. 233.
Morse S., Long J. Infestations / Morse S., Ballard R.C., Holmes K.K. et al. Atlas of Sexually Transmitted Diseases. Edinburgh: Mosby, 2003.
Nathan B., Appiah J., Saunders P. et al. Microscopy outperformed in a comparison of five methods for detecting Trichomonas vaginalis in symptomatic women // Int. J. STD AIDS 2015. Vol. 26. N. 4. P. 251.
Nelson H.D., Helfand M. Screening for chlamydial infection // Am. J. Prev. Med. 2001. N. 20. Suppl. 3. P. 95.
Ness R.B., Hillier S.L., Kip K.E. et al. Bacterial vaginosis and risk of pelvic inflammatory disease // Obstet. Gynecol. 2004. Vol. 104. P. 761.
Ness R.B., Kip K.E., Hillier S.L. et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease // Am. J. Epidemiol. 2005. Vol. 162. N. 6. P. 585.
Newman L., Rowley J., Vander Hoorn S. et al. Estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting // PLoS One. 2015. Vol. 10. N. 12. P. e0143304.
Nicolle L.E., Gupta K., Bradley S.F. et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America // Clin. Infect. Dis. 2019. Vol. 68. N. 10. P. 1611.
Nye M.B., Schwebke J.R., Body B.A. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women // Am. J. Obstet. Gynecol. 2009. Vol. 200. N. 2. P. 188.e1.
Nyirjesy P., Sobel J.D. Genital mycotic infections in patients with diabetes // Postgrad. Med. 2013. Vol. 125. N. 3. P. 33.
Owusu Edusei K. Jr., Bohm M.K., Chesson H.W. et al. Chlamydia screening and pelvic inflammatory disease: insights from exploratory time-series analyses // Am. J. Prev. Med. 2010. Vol. 38. N. 6. P. 652.
Panel on Antiretroviral Guidelines for Adults and Adolescents: Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. 2018.
Park I.U., Introcaso C., Dunne E.F. Human papillomavirus and genital warts: a review of the evidence for the 2015 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines // Clin. Infect. Dis. 2015. Vol. 61. Suppl. 8. P. S849.
Parnham M.J., Erakovic Haber V. et al. Azithromycin: mechanisms of action and their relevance for clinical applications // Pharmacol. Ther. 2014. Vol. 143. P. 225.
Patel E.U., Gaydos C.A., Packman Z.R. et al. Prevalence and correlates of Trichomonas vaginalis infection among men and women in the United States // Clin. Infect. Dis. 2018. Vol. 67. N. 2. P. 211.
Patel H.D., Livsey S.A., Swann R.A. et al. Can urine dipstick testing for urinary tract infection at point of care reduce laboratory workload?// J. Clin. Pathol. 2005. Vol. 58. N. 9. P. 951.
Patton D.L., Halbert S.A., Kuo C.C. et al. Host response to primary Chlamydia trachomatis infection of the fallopian tube in pig-tailed monkeys // Fertil. Steril. 1983. N. 40. P. 829.
Patton D.L., Moore D.E., Spadoni L.R. et al. A comparison of the fallopian tube’s response to overt and silent salpingitis // Obstet. Gynecol. 1989. Vol. 73. P. 622.
Peeling R.W., Ye H. Diagnostic tools for preventing and managing maternal and congenital syphilis: an overview // Bull. World Health Organ. 2004. Vol. 82. N. 6. P. 439.
Persson E., Holmberg K. A longitudinal study of Actinomyces israelii in the female genital tract // Acta. Obstet. Gynecol. Scand. 1984. Vol. 63. P. 207.
Ravel J., Gajer P., Abdo Z. et al. Vaginal microbiome of reproductive-age women // Proc. Natl. Acad. Sci. USA. 2011. Vol. 108. Suppl. 1. P. 4680.
Reed S.D., Landers D.V., Sweet R.L. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agent agents versus clindamycin-containing regimens // Am. J. Obstet. Gynecol. 1991. Vol. 164. N. 6 Pt 1. P. 1556.
Romero L., Huerfano C., Grillo-Ardila C.F. Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults // Cochrane Database Syst. Rev. 2017. N. 12. P. CD012492.
Romosan G., Bjartling C., Skoog L. et al // Ultrasound. for diagnosing acute salpingitis: a prospective observational diagnostic study // Hum. Reprod. 2013. Vol. 28. N. 6. P. 1569.
Rubin R.H., Shapiro E.D., Andriole V.T. et al. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration // Clin. Infect. Dis. 1992. N. 15. Suppl. 1. P. S216.
Sawyer K.P., Stone L.L. Evaluation of a leukocyte dip-stick test used for screening urine cultures // J. Clin. Microbiol. 1984. Vol. 20. N. 4. P. 820.
Schwebke J.R., Gaydos C.A., Nyirjesy P. et al. Diagnostic performance of a molecular test versus clinician assessment of vaginitis // J. Clin. Microbiol. 2018. Vol. 56. N. 6. P. e00252.
Schwebke J.R., Morgan F.G. Jr., Koltun W. et al. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis // Am. J. Obstet. Gynecol. 2017. Vol. 217. N. 6. P. 678.e1.
Selik R.M., Mokotoff E.D., Branson B. et al. Revised surveillance case definition for HIV infection—United States, 2014 // MMWR 2014. Vol. 63. N. 3. P. 1.
Sellors J.W., Mahony J.B., Chernesky M.A. et al. Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis // Fertil. Steril. 1988. Vol. 49. N. 3. P. 451.
Sena A.C., Miller W.C., Hobbs M.M. et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention // Clin. Infect. Dis. 2007. Vol. 44. N. 1. P. 13.
Senok A.C., Verstraelen H., Temmerman M. et al. Probiotics for the treatment of bacterial vaginosis // Cochrane Database Syst. Rev. 2009. N. 4. P. CD006289.
Sherrard J., Wilson J., Donders G. et al. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge // Int. J. STD AIDS 2018. Vol. 29. N. 13. P. 1258.
Shin H., Iwasaki A. Generating protective immunity against genital herpes // Trends. Immunol. 2013. Vol. 34. N. 10. P. 487.
Short V.L., Totten P.A., Ness R.B. et al. Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease // Clin. Infect. Dis. 2009. Vol. 48. N. 1. P. 41.
Soper D.E., Bump R.C., Hurt W.G. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy // Am. J. Obstet. Gynecol. 1990. Vol. 163. P. 1016.
Spence M.R., Blanco L.J., Patel J. et al. A comparative evaluation of vaginal, cervical and peritoneal flora in normal, healthy women: a preliminary report // Sex. Transm. Dis. 1982. Vol. 9. N. 1. P. 37.
Stalenhoef J.E., van der Starre W.E., Vollaard A.M. et al. Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule // BMC Infect. Dis. 2017. Vol. 17. N. 1. P. 400.
Steiner H.L., Strand E.A. Surgical-site infection in gynecologic surgery: pathophysiology and prevention // Am. J. Obstet. Gynecol. 2017. Vol. 217. N. 2. P. 121.
Stemmer S.M., Mordechai E., Adelson M.E. et al. Trichomonas vaginalis is most frequently detected in women at the age of peri-/premenopause: an unusual pattern for a sexually transmitted pathogen // Am. J. Obstet. Gynecol. 2018. Vol. 218. N. 3. P. 328. e1.
Stoner B.P., Cohen S.E. Lymphogranuloma venereum 2015: clinical presentation, diagnosis, and treatment // Clin. Infect. Dis. 2015. Vol. 61. N. 8. P. S865.
Stoner K.A., Rabe L.K., Meyn L.A. et: Survival of Trichomonas vaginalis in wet preparation and on wet mount // Sex. Transm. Infect. 2013. Vol. 89. N. 6. P. 485.
Susianti H., Lie S. Auto identify discrepancies between urine test strip and sediment results using cross check function on fully automated urine analyzer // Int. Clin. Pathol. J. 2015. Vol. 1. N. 4. P. 87.
Tatti S., Swinehart J.M., Thielert C. et al. Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial // Obstet. Gynecol. 2008. Vol. 111. N. 6. P. 1371.
Tepper N.K., Steenland M.W., Gaffield M.E. et al. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review // Contraception. 2013. Vol. 87. N. 5. P. 655.
Thurman A.R., Satterfield T.M., Soper D.E. Methicillin-resistant Staphylococcus aureus as a common cause of vulvar abscesses // Obstet. Gynecol. 2008. Vol. 112. P. 538.
Tiitinen A., Surcel H.M., Halttunen M. et al. Chlamydia trachomatis and chlamydial heat shock protein 60-specific antibody and cell-mediated responses predict tubal factor infertility // Hum. Reprod. 2006. Vol. 21. N. 6. P. 1533.
Timor-Tritsch I.E., Lerner J.P., Monteagudo A. et al. Transvaginal sonographic markers of tubal inflammatory disease // Ultrasound Obstet. Gynecol. 1998. Vol. 12. N. 1. P. 56.
Tjiam K.H., Zeilmaker G.H., Alberda A.T. et al. Prevalence of antibodies to Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in infertile women // Genitourin. Med. 1985. Vol. 61. N. 3. P. 175.
Toth M., Patton D.L., Campbell L.A. et al. Detection of chlamydial antigenic material in ovarian, prostatic, ectopic pregnancy and semen samples of culture-negative subjects // Am. J. Reprod. Immunol. 2000. Vol. 43. N. 4. P. 218.
Trent M., Coleman J.S., Hardick J. et al. Clinical and sexual risk correlates of Mycoplasma genitalium in urban pregnant and non-pregnant young women: cross-sectional outcomes using the baseline data from the Women’s BioHealth Study // Sex. Transm. Infect. 2018. Vol. 94. N. 6. P. 411.
Tyring S.K. Molluscum contagiosum: the importance of early diagnosis and treatment // Am. J. Obstet. Gynecol. 2003. Vol. 189. N. 3. P. S12.
Uppal S., Harris J., Al-Niaimi A. et al. Prophylactic antibiotic choice and risk of surgical site infection after hysterectomy // Obstet. Gynecol. 2016. Vol. 127. N. 2. P. 321.
U.S. Preventive Services Task Force: Clinical summary. Chlamydia and gonorrhea: screening. 2014.
U.S Preventive Services Task Force: Preexposure prophylaxis for the prevention of HIV infection: recommendation statement // JAMA 2019. Vol. 321. P. 22.
van der Wouden J.C., van der Sande R., Kruithof E.J. et al. Interventions for cutaneous molluscum contagiosum // Cochrane Database Syst. Rev. 2017. Vol. 5. P. CD004767.
Watts D.H., Krohn M.A., Hillier S.L. et al. Bacterial vaginosis as a risk factor for postcesarean endometritis // Obstet. Gynecol. 1990. Vol. 75. P. 52.
Weisenfeld H.C., Manhart L.E. Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen // J. Inf. Dis. 2017. Vol. 216. Suppl. 2. P. S389.
Weller S., Davis K. Condom effectiveness in reducing heterosexual HIV transmission // Cochrane Database Syst. Rev. 2002. N. 1. P. CD003255.
Wendel G.D. Jr., Stark B.J., Jamison R.B. et al. Penicillin allergy and desensitization in serious infections during pregnancy // N. Engl. J. Med. 1985. Vol. 312. P. 1229.
Werner R.N., Westfechtel L., Dressler C. et al. Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis // Sex. Transm. Infect. 2017. Vol. 93. N. 3. P. 155.
Westhoff C. IUDs and colonization or infection with Actinomyces // Contraception. 2007. Vol. 75. P. S48.
Westrom L., Joesoef R., Reynolds G. et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results // Sex. Transm. Dis. 1992. N. 19. P. 185.
Wiese W., Patel S.R., Patel S.C. et al. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis // Am. J. Med. 2000. Vol. 108. N. 4. P. 301.
Wiesenfeld H.C., Hillier S.L., Krohn M.A. et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection // Clin. Infect. Dis. 2003. Vol. 36. N. 5. P. 663.
Wiesenfeld H.C., Hillier S.L., Meyn L.A. et al. Subclinical pelvic inflammatory disease and infertility // Obstet. Gynecol. 2012. Vol. 120. N. 1. P. 37.
Wiesenfeld H.C., Sweet R.L., Ness R.B. et al. Comparison of acute and subclinical pelvic inflammatory disease // Sex. Transm. Dis. 2005. Vol. 32. N. 7. P. 400.
Williams J.A., Ofner S., Batteiger B.E. et al. Duration of polymerase chain reaction-detectable DNA after treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections in women // Sex. Transm. Dis. 2014. Vol. 41. N. 3. P. 215.
Wilson J. Managing recurrent bacterial vaginosis // Sex. Transm. Infect. 2004. Vol. 80. P. 8.
Xie H.Y., Feng D., Wei D.M. et al. Probiotics for vulvovaginal candidiasis in non-pregnant women // Cochrane Database Syst. Rev. 2017. N. 11. P. CD010496.
Yan J., Chen S.L., Wang H.N. et al. Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminate // Dermatology. 2006. Vol. 213. N. 3. P. 218.
Abrams B.J., Sukmvanich P., Seibel R. et al // Ultrasound. for the detection of intraperitoneal fluid: the role of Trendelenburg position // Am. J. Emerg. Med. 1999. Vol. 17. P. 117.
Abuhamad A.Z., Singleton S., Zhao Y. et al. The Z technique: an easy approach to the display of the mid-coronal plane of the uterus in volume sonography // J. Ultrasound. Med. 2006. Vol. 25. P. 607.
Adusumilli S., Hussain H.K., Caoili E.M. et al. MR imaging of sonographically indeterminate adnexal masses // AJR 2006. Vol. 187. P. 732.
Alcazar J.L., Galan M.J., Garcia-Manero M. et al. Three-dimensional sonographic morphologic assessment in complex adnexal masses: preliminary experience // J. Ultrasound. Med. 2003. Vol. 22. P. 249.
Alcazar J.L., Martinez-Astorquiza Corral T., Orozco R. et al. Three-dimensional hysterosalpingo-contrast-sonography for the assessment of tubal patency in women with infertility: a systematic review with meta-analysis // Gynecol. Obstet. Invest. 2016. Vol. 81. N. 4. P. 289.
American College of Obstetricians and Gynecologists: Sonohysterography. Technology Assessment. N. 12, August 2016.
American College of Obstetricians and Gynecologists: Prevention of infection after gynecologic procedures. Technology Assessment. N. 12, August 2016.
American College of Radiology: ACR Manual on Contrast Media. Reston: American College of Radiology, 2018.
American College of Radiology: ACR practice parameter for performing and interpreting magnetic resonance imaging (MRI). Reston: American College of Radiology, 2017.
American Institute of Ultrasound in Medicine: Guidelines for performance of the ultrasound examination of the female pelvis. 2014. Accessed April 22, 2019.
American Institute of Ultrasound in Medicine: Official statement on heat // AIUM Bioeffects Committee. 2009.
Ameye L., Valentin L., Testa A.C. et al. A scoring system to differentiate malignant from benign masses in specific ultrasound-based subgroups of adnexal tumors // Ultrasound Obstet. Gynecol. 2009. Vol. 33. P. 92.
Ascher S.M., Arnold L.L., Patt R.H. et al. Adenomyosis: prospective comparison of MR imaging and transvaginal sonography // Radiology. 1994. Vol. 190. P. 803.
Ascher S.M., Jha R.C., Reinhold C. Benign myometrial conditions: leiomyomas and adenomyosis // Top Magn. Reson. Imaging. 2003. N. 14. P. 281.
Ascher S.M., Takahama J., Jha R.C. Staging of gynecologic malignancies // Top Magn. Reson. Imaging 2001. N. 12. P. 105.
Bates S.M., Ginsberg J.S. Treatment of deep-vein thrombosis // N. Engl. J. Med. 2004. Vol. 351. P. 268.
Bazot M., Darai E., Hourani R. et al. Deep pelvic endometriosis: MR imaging for diagnosis and prediction of extension of disease // Radiology. 2004. Vol. 232. P. 379.
Behr S., Courtier J., Qayyum A. Imaging of m?llerian duct anomalies // Radiographics. 2012. N. 32. P. E233.
Benacerraf B.R., Shipp T.D., Bromley B. Three-dimensional ultrasound detection of abnormally located intrauterine contraceptive devices which are a source of pelvic pain and abnormal bleeding // Ultrasound Obstet. Gynecol. 2009. N. 34. P. 110.
Benacerraf B.R., Shipp T.D., Bromley B. Which patients benefit from a 3D reconstructed coronal view of the uterus added to standard routine 2D pelvic sonography? // AJR 2008. Vol. 190. P. 626.
Bermejo C., Martinez Ten P., Cantarero R. et al. Three-dimensional ultrasound in the diagnosis of m?llerian duct anomalies and concordance with magnetic resonance imaging // Ultrasound Obstet. Gynecol. 2010. Vol. 35. P. 593.
Beyersdorff D., Zhang J., Schoder H. et al. Bladder cancer: can imaging change patient management? // Curr. Opin. Urol. 2008. N. 18. P. 98.
Birdwell B.G., Raskob G.E., Whitsett T.L. et al. The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis // Ann. Intern. Med. 1998. Vol. 128. P. 1.
Bonnamy L., Marret H., Perrotin F. et al. Sonohysterography: a prospective survey of results and complications in 81 patients // Eur. J. Obstet. Gynecol. Reprod. Biol. 2002. Vol. 102. P. 42.
Boronow R.C., Morrow C.P., Creasman W.T. et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study // Obstet. Gynecol. 1984. Vol. 63. P. 825.
Branney S.W., Wolfe R.E., Moore E.E. et al. Quantitative sensitivity of ultrasound in detecting free intraperitoneal fluid // J. Trauma. 1995. Vol. 39. P. 375.
Buy J.N., Ghossain M.A., Hugol D. et al. Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone // AJR 1996. Vol. 166. P. 385.
Cacciatore B., Leminen A., Ingman-Friberg S. et al. Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease // Obstet. Gyncol. 1992. Vol. 80. P. 912.
Capitanio G.L., Ferraiolo A., Croce S. et al. Transcervical selective salpingography: a diagnostic and therapeutic approach to cases of proximal tubal injection failure // Fertil. Steril. 1991. Vol. 55. P. 1045.
Carretti M., Dos Santos Sim?es R., Bernardo W.M. et al. Accuracy of ultrasonography in the evaluation of tubal sterilization microinsert positioning: systematic review and meta-analysis // J // Ultrasound. Med. 2019. Vol. 38. P. 289.
Chamie L., Blasalg R., Pereira R. et al. Findings of pelvic endometriosis at transvaginal US, MR imaging, and laparoscopy // Radiographics. 2011. Vol. 31. P. E77.
Chan D.P., Abujudeh H.H., Cushing G.L. Jr. et al. CT cystography with multiplanar reformation for suspected bladder rupture: experience in 234 cases // AJR 2006. Vol. 187. P. 1296.
Abdeen G., le Roux C.W. Mechanism underlying the weight loss and complications of Roux-en-Y gastric bypass // Obes. Surg. 2016. Vol. 26. N. 2. P. 410.
Acierno R., Hernandez M.A., Amstadter A.B. et al. Prevalence and correlates of emotional, physical, sexual, and financial abuse and potential neglect in the United States: the National Elder Mistreatment Study // Am. J. Public Health. 2010. Vol. 100. N. 2. P. 292.
Acierno R., Hernandez-Tejada M.A., Anetzberger G.J. et al. The National Elder Mistreatment Study: an 8-year longitudinal study of outcomes // J. Elder. Abuse Negl. 2017. Vol. 29. N. 4. P. 254.
Adams J.A., Farst K.J., Kellogg N.D. Interpretation of medical findings in suspected child sexual abuse: an update for 2018 // J. Pediatr. Adolesc. Gynecol. 2018. Vol. 31. N. 3. P. 225.
Adams J.A., Kaplan R.A., Starling S.P. et al. Guidelines for medical care of children who may have been sexually abused // J. Pediatr. Adolesc. Gynecol. 2007. N. 20. P. 163.
Almroth L., Elmusharaf S., El Hadi N. et al. Primary infertility after genital mutilation in girlhood in Sudan: a case-control study // Lancet. 2005. Vol. 366. P. 385.
American Academy of Family Physicians: Screening pelvic exam. 2017. Available at: www.aafp.org/patient-care/clinical-recommendations/ all/screening-pelvic-exam.html Accessed November 19, 2018.
American College of Obstetricians and Gynecologists: Health care for transgender individuals. Committee Opinion. N. 512. December 2011.
American College of Obstetricians and Gynecologists: Intimate partner violence. Committee Opinion. N. 518. February 2012.
American College of Obstetricians and Gynecologists: Guidelines for Women’s Health Care. Washington: ACOG, 2014.
American College of Obstetricians and Gynecologists: Sexual assault // Committee Opinion. N. 592. April 2014. Reaffirmed 2016 a.
American College of Obstetricians and Gynecologists: The initial reproductive health visit // Committee Opinion. N. 598. May 2014. Reaffirmed 2016 b.
American College of Obstetricians and Gynecologists: Well-woman visit // Committee Opinion. N. 534. August 2012. Reaffirmed 2016 c.
American College of Obstetricians and Gynecologists: Bariatric surgery and pregnancy // Practice Bulletin. N. 105. June 2009. Reaffirmed 2017 a.
American College of Obstetricians and Gynecologists: Breast cancer risk assessment and screening in average-risk women // Practice Bulletin. N. 179. July 2017 b.
American College of Obstetricians and Gynecologists: Physical activity and exercise during pregnancy and the postpartum period // Committee Opinion. N. 650. December 2015. Reaffirmed 2017 c.
American College of Obstetricians and Gynecologists: Routine human immunodeficiency virus screening // Committee Opinion. N. 596. May 2014. Reaffirmed 2017 d.
American College of Obstetricians and Gynecologists: Carrier screening in the age of genomic medicine // Committee Opinion. N. 690. March 2017 e.
American College of Obstetricians and Gynecologists: Hormone therapy and heart disease // Committee Opinion. N. 565. June 2013. Reaffirmed 2018 a.
American College of Obstetricians and Gynecologists: The utility of and indications for routine pelvic examination // Committee Opinion. N. 754. October 2018 b.
American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine: Prepregnancy Counseling // Committee Opinion. N. 762. January 2019.
American Diabetes Association: 2. Classification and diagnosis of diabetes: standards of medical care in diabetes — 2019 // Diabetes Care 2019. N. 42. Suppl. 1. P. S13.
American Heart Association: Understanding blood pressure readings. 2017.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Arlington: APA, 2013.
Andersson S.H., Rymer J., Joyce D.W. et al. Sexual quality of life in women who have undergone female genital mutilation: a case-control study // BJOG 2012. Vol. 119. N. 13. P. 1606.
Arias E., Heron M., Xu J. United States life tables, 2014 // Natl. Vital. Stat. Rep. 2017. Vol. 66. N. 4. P. 1.
Astrup B.S., Ravn P., Lauritsen J. et al. Nature, frequency and duration of genital lesions after consensual sexual intercourse: implications for legal proceedings // Forensic. Sci. Int. 2012. Vol. 219. P. 50.
Baker F.C., de Zambotti M., Colrain I.M. et al. Sleep problems during the menopausal transition: prevalence, impact, and management challenges / Nat. Sci. Sleep. 2018. N. 10. P. 73.
Barboza J.L., Patel R., Patel P. et al. An update on the pharmacotherapeutic interventions for smoking cessation / Expert. Opin. Pharmacother. 2016. Vol. 17. N. 11. P. 1483.
Basile K.C., Breiding M.J., Smith S.G: Disability and risk of recent sexual violence in the United States / Am. J. Public Health. 2016. Vol. 106. N. 5. P. 928.
Basile K.C., Hertz M.F., Back S.E. Intimate partner violence and sexual violence victimization assessment instruments for use in healthcare settings: version 1. Atlanta: Centers for Disease Control and Prevention, 2007.
Basile K.C., Smith S.G., Breiding M.J. et al. Sexual violence surveillance: uniform definitions and recommended data elements, version 2.0. Atlanta: National Center for Injury Prevention and Control, 2014.
Benjamin E.J., Virani S.S., Callaway C.W. et al. Heart disease and stroke statistics — 2018 update: a report from the American Heart Association // Circulation. 2018. Vol. 137. N. 12. P. e67.
Berg R.C., Taraldsen S., Said M.A. et al. The effectiveness of surgical interventions for women with FGM/C: a systematic review / BJOG. 2018. Vol. 125. N. 3. P. 278.
Bhasin S., Cunningham G.R., Hayes F.J. et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline / J. Clin. Endocrinol. Metab. 2006. Vol. 91. N. 6. P. 1995.
Bibbins-Domingo K. U.S. Preventive Services Task Force: Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement / Ann. Intern. Med. 2016. Vol. 164. P. 836.
Borson S., Scanlan J., Brush M. et al. The Mini-Cog: a cognitive “vital signs” measure for dementia screening in multi-lingual elderly / Int. J. Geriatr. Psychiatry 2000. N. 15. P. 1021.
Bray G., Look M., Ryan D. Treatment of the obese patient in primary care: targeting and meeting goals and expectations // Postgrad. Med. 2013. Vol. 125. N. 5. P. 67.
Breiding M.J., Basile K.C., Smith S.G. et al. Intimate partner violence surveillance: uniform definitions and recommended data elements, version 2.0. Atlanta: National Center for Injury Prevention and Control, 2015.
Briggs G.G., Freeman R.K., Tower C.V. et al. Drugs in Pregnancy and Lactation. Philadelphia: Wolters Kluwer, 2017. 1079 p.
Burgess A.W., Holmstrom L.L. Rape trauma syndrome // Am. J. Psychiatry 1974. Vol. 131. N. 9. P. 981.
Buysse D.J. Insomnia // JAMA 2013. Vol. 309. N. 7. P. 706.
Campbell J.C: Health consequences of intimate partner violence // Lancet. 2002. Vol. 359. Issue 9314. P. 1331.
Centers for Disease Control and Prevention: Adverse health conditions and health risk behaviors associated with intimate partner violence — United States, 2005 // MMWR 2008. Vol. 57. N. 5. P. 113.
Centers for Disease Control and Prevention: Interim statement regarding potential fetal harm from exposure to dolutegravir — implications for HIV post-exposure prophylaxis. N. PEP). 2018a.
Centers for Disease Control and Prevention: National diabetes statistics report. Atlanta, U.S. Department of Health and Human Services, 2017.
Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, 2015 // MMWR 2015. Vol. 64. N. 3. P. 1.
Centers for Disease Control and Prevention: Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV — United States. 2016.
Centers for Disease Control and Prevention: US Public Health Service: preexposure prophylaxis for the prevention of HIV infection in the United States — 2017 update: a clinical practice guideline.
Centers for Disease Control and Prevention: Women and their partners trying to become pregnant.
Chiesa A., Goldson E. Child sexual abuse // Pediatr. Rev. 2017. Vol. 38. N. 3. P. 105.
Child Welfare Information Gateway: Mandatory reporters of child abuse and neglect. Washington: Department of Health and Human Services, 2016.
Curtis K.M., Jatlaoui T.C., Tepper N.K. et al. U.S. selected practice recommendations for contraceptive use // MMWR 2016. Vol. 65. N. 4. P. 1.
Davies M.J., Bergenstal R., Bode B. et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial // JAMA 2015. Vol. 314. P. 687.
De Schrijver L., Leye E., Merckx M. A multidisciplinary approach to clitoral reconstruction after female genital mutilation: the crucial role of counselling / Eur. J. Contracept. Reprod. Health Care. 2016. Vol. 21. N. 4. P. 269.
de Vries A.L., McGuire J.K., Steensma T.D. et al. Young adult psychological outcome after puberty suppression and gender reassignment // Pediatrics. 2014. Vol. 134. N. 4. P. 696.
de Vries A.L., Steensma T.D., Doreleijers T.A. et al. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study / J. Sex. Med. 2011. Vol. 8. N. 8. P. 2276.
Department of Justice: A national protocol for sexual assault medical forensic examinations: adults/adolescents, second edition. Washington, Office on Violence Against Women, 2013.
Department of Justice: State elder abuse statutes. 2016.
Deutsch MB: Overview of feminizing hormone therapy. 2018.
Dooling K.L., Guo A., Patel M. et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines // MMWR 2018. Vol. 67. P. 103.
Durborow N., Lizdas K.C., O’Flaherty A. et al. Compendium of state and U.S. territory statutes and policies on domestic violence and health care. San Francisco: Futures Without Violence, 2013.
Eckel R.H., Jakicic J.M., Ard J.D. et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines // Circulation. 2014. Vol. 129. N. 25. Suppl. 2. P. S76.
Federal Bureau of Investigation: Summary reporting system. N. SRS) user manual version 1.0. 2013.
Fedina L., Holmes J.L., Backes B.L. Campus sexual assault: a systematic review of prevalence research from 2000 to 2015 // Trauma Violence Abuse. 2018. Vol. 19. N. 1. P. 76.
Fiore M.C., Jaen C.R., Baker T.B. et al. Treating tobacco use and dependence: 2008 update. Rockville, U.S.: Department of Health and Human Services, 2008.
Flores A.R., Herman J.L., Gates G.J. et al. How many adults identify as transgender in the United States? Los Angeles: The Williams Institute, 2016.
Food and Drug Administration: Completed safety review of Xenical/Alli. N. orlistat) and severe liver injury. 2010.
Food and Drug Administration: FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. 2018.
Fredriksen-Goldsen K.I., Cook-Daniels L., Kim H.J. et al. Physical and mental health of transgender older adults: an at-risk and underserved population // Gerontologist. 2014. Vol. 54. N. 3. P. 488.
Futterweit W. Endocrine therapy of transsexualism and potential complications of long-term treatment // Arch. Sex. Behav. 1998. Vol. 27. N. 2. P. 209.
Ganly I., Taylor E.W. Breast cancer in a trans-sexual man receiving hormone replacement therapy // Br. J. Surg. 1995. N. 82. P. 341.
Garber A.J., Abrahamson M.J., Barzilay J.I. et al. Consensus statement by the AACE and ACE on the comprehensive type 2 diabetes management algorithm — 2018 executive summary // Endocr. Pract. 2018. Vol. 24. N. 1. P. 91.
Gay and Lesbian Medical Association: Guidelines for care of lesbian, gay, bisexual and transgender patients. Washington: GLMA, 2006.
Girardet R.G., Lahoti S., Howard L.A. et al. Epidemiology of sexually transmitted infections in suspected child victims of sexual assault // Pediatrics. 2009. Vol. 124. N. 1. P. 79.
Girardet R.G., Lemme S., Biason T.A. et al. HIV post-exposure prophylaxis in children and adolescents presenting for reported sexual assault // Child. Abuse Negl. 2009. N. 33. P. 173.
Goldberg H., Stupp P., Okoroh E. et al. Female genital mutilation/cutting in the United States: updated estimates of women and girls at risk, 2012 // Public. Health Rep. 2016. Vol. 131. N. 2. P. 340.
Gorin-Lazard A., Baumstarck K., Boyer L. Is hormonal therapy associated with better quality of life in transsexuals? A cross sectional study // J. Sex. Med. 2012. Vol. 9. N. 2. P. 531.
Griffith W.F., Stuart G.S., Gluck K.L. et al. Vaginal speculum lubrication and its effects on cervical cytology and microbiology // Contraception. 2005. Vol. 72. N. 1. P. 60.
Grundy S.M., Cleeman J.I., Daniels S.R. et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement // Circulation. 2005. Vol. 112. N. 17. P. 2735.
Grundy S.M., Stone N.J., Bailey A.L. et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol // Circulation. 2019. Vol. 139. N. 25. P. e1082.
Hales C.M., Fryar C.D., Carroll M.D. et al. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016 // JAMA 2018. Vol. 319. N. 16. P. 1723.
Hall J.E., Karch D.L., Crosby A.E. Elder abuse surveillance: uniform definitions and recommended core data elements for use in elder abuse surveillance, version 1.0. Atlanta: National Center for Injury Prevention and Control, 2016.
Hartmann D., G?zelhan C., Zuiderwijk P.B. et al. Lack of interaction between orlistat and oral contraceptives. Eur J Clin Pharmacol 50. N. 5. P. 421, 1996.
Hawkins JS, Casey BM: Obesity / Cunningham F.G., Leveno K.L., Bloom S.L. et al. Williams Obstetrics. New York: McGraw-Hill, 2018.
Hembree W.C., Cohen-Kettenis P.T., Gooren L. et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline // J. Clin. Endocrinol. Metab. 2017. Vol. 102. N. 11. P. 3869.
Holmes M.M., Resnick H.S., Kilpatrick D.G. et al. Rape-related pregnancy: estimates and descriptive characteristics from a national sample of women // Am. J. Obstet. Gynecol. 1996. Vol. 175. N. 2. P. 320.
Hoover R.M., Polson M. Detecting elder abuse and neglect assessment and intervention // Am. Fam. Physician. 2014. Vol. 89. N. 6. P. 453.
Imperiale T.F., Ransohoff D.F., Itzkowitz S.H. et al. Multitarget stool DNA testing for colorectal-cancer screening // N. Engl. J. Med. 2014. Vol. 370. N. 14. P. 1287.
Institute of Medicine: Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington: The National Academies Press, 2002.
Iverson K.M., McLaughlin K.A., Gerber M.R. et al. Exposure to interpersonal violence and its associations with psychiatric morbidity in a U.S. national sample: a gender comparison // Psychol. Violence. 2013. Vol. 3. N. 3. P. 273.
Jack B.W., Atrash H., Coonrod D.V. et al. The clinical content of preconception care: an overview and preparation of this supplement // Am. J. Obstet. Gynecol. 2008. Vol. 199. N. 6 Suppl. 2. P. S266.
Jack S.P., Petrosky E., Lyons B.H. et al. Surveillance for violent deaths—National Violent Death Reporting System, 27 states, 2015 // MMWR 2018. Vol. 67. N. 11. P. 1.
Janssen J., Koekkoek P.S., Moll van Charante E.P. et al. How to choose the most appropriate cognitive test to evaluate cognitive complaints in primary care // BMC Fam. Pract. 2017. Vol. 18. N. 1. P. 101.
Jellinger P.S., Handelsman Y., Rosenblit P.D. et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease — executive summary // Endocr. Pract. 2017. Vol. 23. N. 4. P. 479.
Jenny C., Hooton T.M., Bowers A. et al. Sexually transmitted diseases in victims of rape // N. Engl. J. Med. 1990. Vol. 322. N. 11. P. 713.
Jensen M.D., Ryan D.H., Apovian C.M. et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society // Circulation. 2014. Vol. 129. N. 25. Suppl. 2. P. S102.
Jung H., Herrenkohl T.I., Skinner M.L. et al. Gender differences in intimate partner violence: a predictive analysis of IPV by child abuse and domestic violence exposure during early childhood // Violence Against Women. 2019. Vol. 25. N. 8. P. 903.
Kahn R., Buse J., Ferrannini E. et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes // Diabetes Care 2005. Vol. 28. N. 9. P. 2289.
Killin B.A. Antiobesity drugs in early pregnancy and congenital malformations in the offspring // Obes. Res. Clin. Pract. 2014. Vol. 8. N. 6. P. e571.
Kann L., McManus T., Harris W.A. et al. Youth risk behavior surveillance — United States, 2017 // MMWR 2018. Vol. 67. N. 8. P. 1.
Katz S., Ford A.B., Moskowitz R.W. et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function // JAMA 1963. Vol. 185. P. 914.
Khera R., Murad M.H., Chandar A.K. et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis // JAMA 2016. Vol. 315. N. 22. P. 2424.
Kim D.K., Hunter P. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older — United States, 2019 // MMWR 2019. Vol. 68. N. 5. P. 115.
Kasters J.P., G?tzsche P.C: Regular self-examination or clinical examination for early detection of breast cancer // Cochrane Database Syst. Rev. 2008. N. 3. P. CD003373.
Krause E., Brandner S., Mueller M.D. et al. Out of Eastern Africa: defibulation and sexual function in woman with female genital mutilation / J. Sex. Med. 2011. Vol. 8. N. 5. P. 1420.
Kroenke K., Spitzer R.L., Williams J.B. The Patient Health Questionnaire–2: validity of a two-item depression screener // Med. Care. 2003. Vol. 41. N. 11. P. 1284.
Kushner R.F. Weight loss strategies for treatment of obesity: lifestyle management and pharmacotherapy // Prog. Cardiovasc. Dis. 2018. Vol. 61. N. 2. P. 246.
Lachs M.S., Pillemer K.A. Elder abuse // N. Engl. J. Med. 2015. Vol. 373. N. 20. P. 1947.
Larsen M.L., Hilden M., Lidegaard ?. Sexual assault: a descriptive study of 2500 female victims over a 10-year period / BJOG 2015. Vol. 122. N. 4. P. 577.
Lawton M.P., Brody E.M. Assessment of older people: self-monitoring and instrumental activities of daily living // Gerontologist. 1969. N. 9. P. 179.
LeFevre M.L., U.S. Preventive Services Task Force: Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement // Ann. Intern. Med. 2014. Vol. 161. N. 12. P. 902.
LeFevre M.L. U.S. Preventive Services Task Force: Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive Services Task Force recommendation statement // Ann. Intern. Med. 2014. Vol. 161. N. 1. P. 58.
LeFevre M.L. U.S. Preventive Services Task Force: Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement // Ann. Intern. Med. 2015. Vol. 162. N. 9. P. 641.
Lenahan L.C., Ernst A., Johnson B. Colposcopy in evaluation of the adult sexual assault victim // Am. J. Emerg. Med. 1998. Vol. 16. N. 2. P. 183.
Light A.D., Obedin-Maliver J., Sevelius J.M. et al. Transgender men who experienced pregnancy after female-to-male gender transitioning // Obstet. Gynecol. 2014. Vol. 124. N. 6. P. 1120.
Linden J.A. Care of the adult patient after sexual assault // N. Engl. J. Med. 2011. Vol. 365. P. 834.
Mayer K., Bradford J., Makadon H. et al. Sexual and gender minority health: what we know and what needs to be done // Am. J. Public Health. 2008. Vol. 98. N. 6. P. 989.
McDonald S., Saslow D., Alciati M.H. Performance and reporting of clinical breast examination: a review of the literature // CA Cancer J. Clin. 2004. Vol. 54. P. 345.
Merhi Z.O. Impact of bariatric surgery on female reproduction // Fertil. Steril. 2009. Vol. 92. N. 5. P. 1501.
Merrick M.T., Basile K.C., Zhang X. et al. Characterizing sexual violence victimization in youth: 2012 National Intimate Partner and Sexual Violence Survey // Am. J. Prev. Med. 2018. Vol. 54. N. 4. P. 596.
Monstrey S., De Cuypere G., Ettner R. Surgery: female-to-male patient / Ettner S.R., Monstrey S., Eyler A.E. Principles of Transgender Medicine and Surgery. New York: Haworth Press, 2007. 135 р.
Moore E., Wisniewski A., Dobs A. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects // J. Clin. Endocrinol. Metab. 2003. Vol. 88. P. 3467.
Mosca L., Benjamin E.J., Berra K. et al. Effectiveness-based guidelines for prevention of cardiovascular disease in women—2011 update // Circulation. 2011. Vol. 123. P. 1243.
Moyer V.A. U.S. Preventive Services Task Force: Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement // Ann. Intern. Med. 2013. Vol. 159. N. 5. P. 349.
Moyer V.A. U.S. Preventive Services Task Force: Screening for HIV: U.S. Preventive Services Task Force recommendation statement // Ann. Intern. Med. 2013. Vol. 159. N. 1. P. 51.
Nasreddine Z.S., Phillips N.A., Bedirian V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment // J. Am. Geriatr. Soc. 2005. Vol. 53. N. 4. P. 695.
National Adult Protective Services: Get help. 2018.
National District Attorney Association: Reporting requirements related to rape of competent adult victims. Arlington: National District Attorney Association, 2016.
National Heart, Lung, and Blood Institute: Managing overweight and obesity in adults: systematic evidence review from the obesity expert panel, 2013.
Nour N.M., Michels K.B., Bryant A.E. Defibulation to treat female genital cutting: effect on symptoms and sexual function // Obstet. Gynecol. 2006. Vol. 108. N. 1. P. 55.
Novo Nordisk: Saxenda REMS program. 2017.
Oeffinger K.C., Fontham E.T., Etzioni R. et al. Breast cancer screening for women at average risk: 2015 Guideline Update from the American Cancer Society // JAMA 2015. Vol. 314. N. 15. P. 1599.
O’Hanlan K.A., Dibble S.L., Young-Spint M. Total laparoscopic hysterectomy for female-to-male transsexuals // Obstet. Gynecol. 2007. Vol. 110. N. 5. P. 1096.
Palladino C.L., Singh V., Campbell J. et al. Homicide and suicide during the perinatal period: findings from the National Violent Death Reporting System // Obstet. Gynecol. 2011. Vol. 118. N. 5. P. 1056.
Park D.I., Ryu S., Kim Y.H. et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening // Am. J. Gastroenterol. 2010. Vol. 105. N. 9. P. 2017.
Patel P., Borkowf C.B., Brooks J.T. et al. Estimating per-act HIV transmission risk: a systematic review // AIDS 2014. Vol. 28. N. 10. P. 1509.
Pi-Sunyer X., Astrup A., Fujioka K. et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management // N. Engl. J. Med. 2015. Vol. 373. N. 1. P. 11.
Piercy K.L., Troiano R.P., Ballard R.M. et al. The physical activity guidelines for Americans // JAMA 2018. Vol. 320. N. 19. P. 2020.
Qaseem A., Humphrey L.L., Harris R. et al. Screening pelvic examination in adult women: a clinical practice guideline from the American College of Physicians // Ann. Intern. Med. 2014. Vol. 161. P. 67.
Ray N. Lesbian, gay, bisexual and transgender youth: an epidemic of homelessness. New York: National Gay and Lesbian Task Force Policy Institute, 2006.
Rex D.K., Boland C.R., Dominitz J.A. et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer // Gastroenterology. 2017. Vol. 153. N. 1. P. 307.
Riggs N., Houry D., Long G. et al. Analysis of 1,076 cases of sexual assault // Ann. Emerg. Med. 2000. Vol. 35. N. 4. P. 358.
Sateia M.J., Buysse D.J., Krystal A.D. et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline // J. Clin. Sleep Med. 2017. Vol. 13. N. 2. P. 307.
Schwarcz S.K., Whittington W.L. Sexual assault and sexually transmitted diseases: detection and management in adults and children // Rev. Infect. Dis. 1990. Vol. 12. N. S6. P. 682.
Sena A.C., Hsu K.K., Kellogg N. et al. Sexual assault and sexually transmitted infections in adults, adolescents, and children // Clin. Infect. Dis. 2015. N. 61. Suppl. 8. P. S856.
Shadigian E., Bauer S.T. Pregnancy-associated death: a qualitative systematic review of homicide and suicide // Obstet. Gynecol. Surv. 2005. Vol. 60. N. 3. P. 183.
Shao T., Grossbard M.L., Klein P. Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management // Clin. Breast. Cancer. 2011. Vol. 11. N. 6. P. 417.
Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019 // CA Cancer J. Clin. 2019. Vol. 69. N. 1. P. 7.
Siu A.L. U.S. Preventive Services Task Force: Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement // Ann. Intern. Med. 2015. Vol. 163. N. 8. P. 622.
Siu A.L. U.S. Preventive Services Task Force: Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement // Ann. Intern. Med. 2015. Vol. 163. N. 11. P. 861.
Siu A.L. U.S. Preventive Services Task Force: Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement // Ann. Intern. Med. 2016. Vol. 164. N. 4. P. 279.
Slaughter L., Brown C.R., Crowley S. et al. Patterns of genital injury in female sexual assault victims // Am. J. Obstet. Gynecol. 1997. Vol. 176. N. 3. P. 609.
Smith R.A., Andrews K.S., Brooks D. et al. Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening // CA Cancer J. Clin. 2018. Vol. 68. N. 4. P. 297.
Smith S.G., Chen J., Basile K.C. et al. The National Intimate Partner and Sexual Violence Survey (NISVS): 2010–2012 state report. Atlanta: National Center for Injury Prevention and Control, 2017.
Smith T.D., Raman S.R., Madigan S. et al. Anogenital findings in 3569 pediatric examinations for sexual abuse/assault // J. Pediatr. Adolesc. Gynecol. 2018. Vol. 31. N. 2. P. 79.
Spack N.P. Management of transgenderism // JAMA 2013. Vol. 309. N. 5. P. 478.
Stone N.J., Robinson J.G., Lichtenstein A.H. et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines // Circulation. 2014. Vol. 29. N. 25 Suppl. 2. P. S1.
Tanoue L.T., Tanner N.T., Gould M.K. et al. Lung cancer screening // Am. J. Respir. Crit. Care Med. 2015. Vol. 191. N. 1. P. 19.
Task Force on Postovulatory Methods of Fertility Regulation: Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception // Lancet. 1998. Vol. 352. Issue 9126. P. 428.
Taylor B.G., Mumford E.A. A national descriptive portrait of adolescent relationship abuse: results from the national survey on teen relationships and intimate violence // J. Interpers. Violence. 2016. Vol. 31. N. 6. P. 963.
Thomas D.B., Gao D.L., Ray R.M. Randomized trial of breast self-examination in Shanghai: final results // J. Natl. Cancer Inst. 2002. Vol. 94. N. 19. P. 1445.
Trussell J., Ellertson C., Stewart F. The effectiveness of the Yuzpe regimen of emergency contraception // Fam. Plann. Perspect. 1996. Vol. 28. N. 2. P. 58.
UNICEF: Female genital mutilation/cutting: a global concern. 2016.
U.S. Department of Health and Human Services: Physical Activity Guidelines for Americans, 2nd ed. Washington: U.S. Department of Health and Human Services, 2018.
U.S. Preventive Services Task Force: Colon cancer: screening. 2016.
U.S. Preventive Services Task Force: Draft recommendation statement hepatitis C virus infection in adolescents and adults: screening.
U.S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC: Screening for gynecologic conditions with pelvic examination: US Preventive Services Task Force recommendation statement // JAMA 2017. Vol. 317. N. 9. P. 947.
U.S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC. et al. Screening for skin cancer: US Preventive Services Task Force recommendation statement // JAMA 2016. Vol. 316. N. 4. P. 429.
U.S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC. et al. Screening for syphilis infection in nonpregnant adults and adolescents: US Preventive Services Task Force recommendation statement // JAMA 2016. Vol. 315. N. 21. P. 2321.
U.S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC. et al. Serologic screening for genital herpes infection: US Preventive Services Task Force recommendation statement // JAMA 2016. Vol. 316. N. 23. P. 2525.
Walters M.L., Chen J., Breiding M.J. The National Intimate Partner and Sexual Violence Survey. N. NISVS. P. 2010 findings on victimization by sexual orientation. Atlanta: National Center for Injury Prevention and Control, 2013.
Whelton P.K., Carey R.M., Aronow W.S. et al. 2017 ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines // Hypertension. 2018. Vol. 71. N. 6. P. 1269.
Wolfe B.M., Kvach E., Eckel R.H. Treatment of obesity: weight loss and bariatric surgery // Circ. Res. 2016. Vol. 118. N. 11. P. 1844.
Wong J.S., Waite L.J. Elder mistreatment predicts later physical and psychological health: results from a national longitudinal study // J. Elder. Abuse Negl. 2017. Vol. 29. N. 1. P. 15.
World Health Organization: Care of Women and Girls Living with Female Genital Mutilation: a Clinical Handbook. Geneva, World Health Organization, 2018.
World Health Organization: Eliminating female genital mutilation. Geneva, World Health Organization, 2008.
World Professional Association for Transgender Health: Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People, 7th ed. 7th Version. Illinois, WPATH, 2012.
Yuzpe A.A., Smith R.P., Rademaker A.W. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent // Fertil. Steril. 1982. Vol. 37. N. 4. P. 508.
Zieman M., Guillebaud J., Weisberg E. et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data // Fertil. Steril. 2002. Vol. 77. P. S13.
Zilkens R.R., Smith D.A., Kelly M.C. et al. Sexual assault and general body injuries: a detailed cross-sectional Australian study of 1163 women // Forensic. Sci. Int. 2017. Vol. 279. P. 112.
Zilkens R.R., Smith D.A., Phillips M.A. et al. Genital and anal injuries: a cross-sectional Australian study of 1266 women alleging recent sexual assault // Forensic. Sci. Int. 2017. Vol. 275. P. 195.
Emily Н. Adhikari, MD, Assistant Professor, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center Medical Director of Perinatal Infectious Disease, Parkland Health and Hospital Systems, Dallas, Texas
Sunil Balgobin, MD, Assistant Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
Rachel A. Bonnema, MD, MS, FACP, Associate Chief, Division of General Internal Medicine, Associate Professor, Department of Internal Medicine, University of Texas Southwestern Medical Center
Anna R. Brandon, PhD, MCS, ABPP, Department of Psychiatry, Division of Clinical Psychology University of Texas Southwestern Medical Center
Alison Brooks Heinzman, MD, FACOG, Director, Medical Student Clerkship, Assistant Professor, Department of Womens Health The University of Texas at Austin Dell Medical School
Matthew J. Carlson, MD, Associate Director, Residency Obstetrics and Gynecology, Assistant Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
Kelley S. Carrick, MD, Professor, Department of Pathology, University of Texas Southwestern Medical Center, Director of Surgical Pathology Images for Williams Gynecology
Stephanie Y. Chang, MD, Associate Director, Residency Obstetrics and Gynecology, Associate Director, Fellowship Minimally Invasive Gynecologic Surgery, Assistant Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
Marlene M. Corton, MD, MSCS, Director, Anatomical Education and Research, Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
F. Gary Cunningham, MD, Beatrice & Miguel Elias Distinguished Chair in Obstetrics and Gynecology, Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
Kevin J. Doody, MD, Director, Center for Assisted Reproduction, Bedford, TX, Clinical Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
David M. Euhus, MD, Professor, Department of Surgery, Johns Hopkins Hospital/University
Veronica Gomez-Lobo, MD, Director of Pediatric and Adolescent Gynecology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Professor of Obstetrics and Gynecology, Georgetown University
William F. Griffith, MD, Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Medical Director, OB/GYN Emergency Services, Director, Vulvology Clinic, Co-Director, Dysplasia Services, Parkland Health and Hospital System, Dallas, Texas
Lisa M. Halvorson, MD, Rockville, Maryland
Cherine A. Hamid, MD, Associate Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Medical Director-Gynecology Clinics, Parkland Health and Hospital Systems, Dallas, Texas
Barbara L. Hoffman, MD, Distinguished Professor in Obstetrics and Gynecology,in Honor of F. Gary Cunningham, M.D., Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
Jason Jarin, MD, Assistant Professor, Department of Obstetrics and Gynecology, Division of Pediatric and Adolescent Gynecology University of Texas, Southwestern Medical Center Children’s Health
Andrew M. Kaunitz, MD, FACOG, NCMP, University of Florida Term Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville, Medical Director and Director of Menopause and, Gynecologic Ultrasound Services, UF Womens Health Specialists-Emerson
Erika L. Kelley, PhD, Assistant Professor, Department of Reproductive Biology, Case Western Reserve University School of Medicine, Clinical Psychologist, Division of Behavioral Medicine, Department of Obstetrics & Gynecology, MacDonald Womens Hospital, University Hospitals Cleveland Medical Center
Kimberly A. Kho, MD, MPH, MSCS, FACOG, Helen J. and Robert S. Strauss and Diana K. and Richard, C. Strauss Chair in Women’s Health, Associate Professor, Department of Obstetrics and Gynecology, Director, Fellowship in Minimally Invasive Gynecologic Surgery, University of Texas Southwestern Medical Center
Young B. Kim, MD, Associate Professor, Department of Obstetrics and Gynecology, Tufts University School of Medicine
Sheryl A. Kingsberg, PhD, Professor, Departments of Reproductive Biology and Psychiatry, Case Western Reserve University School of Medicine, Chief, Division of Behavioral Medicine, Department of Obstetrics & Gynecology, MacDonald Women’s Hospital, University Hospitals Cleveland Medical Center
Alexander Kotlyar, MD, Instructor, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, Yale University
Jayanthi S. Lea, MD, Patricia Duniven Fletcher Distinguished Professor in Gynecologic Oncology, Director, Gynecologic Oncology Fellowship Program, Associate Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
Melissa M. Mauskar, MD, Assistant Professor, Departments of Dermatology and Obstetrics and Gynecology, University of Texas Southwestern Medical Center
John E. Mignano, MD, PhD, Associate Professor, Department of Radiation Oncology Tufts University School of Medicine
David Scott Miller, MD, FACOG, FACS, Dallas Foundation Chair in Gynecologic Oncology Director, Gynecologic Oncology Fellowship Program Director of Gynecologic Oncology, Professor, Department of Obstetrics and Gynecology University of Texas Southwestern Medical Center Medical Director of Gynecology Oncology, Parkland Health and Hospital System, Dallas, Texas
Wilmer Moreno, MD, Assistant Professor, Department of Obstetrics and Gynecology University of Texas Southwestern Medical Center
Elysia Moschos, MD, Professor, Department of Obstetrics and Gynecology University of Texas Southwestern Medical Center Administrative Director of Gynecologic Ultrasound Parkland Health and Hospital System
David M. Owens, MD, Assistant Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
JoAnn V. Pinkerton, MD, FACOG, NCMP, Professor of Obstetrics and Gynecology, Division Director of Midlife Health, The University of Virginia Health System, Charlottesville, Virginia, Emeritus Executive Director, The North American, Menopause Society
David D. Rahn, MD, Associate Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
Debra L. Richardson, MD, FACOG, FACS, Associate Professor, Department of Obstetrics and Gynecology, Stephenson Cancer Center, University of Oklahoma, Health Sciences Center
David E. Rogers, MD, MBA, Associate Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
John O. Schorge, MD, FACOG, FACS, Chief, Division of Gynecologic Oncology, Professor, Department of Obstetrics and Gynecology, Tufts University School of Medicine
Joseph I. Schaffer, MD, MBA, Holder, Frank C. Erwin, Jr. Professorship in Obstetrics and Gynecology, Director, Division of Gynecology, Director, Division of Female Pelvic Medicine and Reconstructive Surgery, Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Chief of Gynecology, Parkland Health and Hospital System, Dallas, Texas
Geetha Shivakumar, MD, MSCS, Mental Health Trauma Services, Dallas VA, Medical Center, Associate Professor, Department of Psychiatry, University of Texas Southwestern Medical Center
Gretchen S. Stuart, MD, MPHTM, FACOG, Director, Family Planning Program, Director, Fellowship in Family Planning, Professor, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill
Hugh S. Taylor, MD, Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale University
Mayra J. Thompson, MD, FACOG, Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
Diane M. Twickler, MD, FACR, Dr. Fred Bonte Professorship in Radiology, Distinguished Teaching Professor, Department of Radiology Vice Chairman for Academic Affairs, Professor, Departments of Radiology and Obstetrics and Gynecology, University of Texas Southwestern Medical Center
Clifford Y. Wai, MD, Director, Fellowship Program in Female Pelvic Medicine and Reconstructive Surgery, Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
Claudia L. Werner, MD, Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Medical Director of Dysplasia Services, Co-Director Vulvology Clinic, Parkland Health and Hospital System, Dallas, Texas
Ellen E. Wilson, MD, Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Director of Pediatric and Adolescent Gynecology Program, Childrens Medical Center, Dallas, Texas
Choi S.H., Kim S.H. Choi H.J. et al. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study // J. Comput. Assist. Tomogr. 2004. Vol. 28. P. 620.
Chou C.P., Levenson R.B., Elsayes K.M. et al. Imaging of female urethral diverticulum: an update // Radiographics. 2008. Vol. 28. N. 7. P. 1917.
Cohen H.L., Tice H.M., Mandel F.S. Ovarian volumes measured by US: bigger than we think // Radiology. 1990. Vol. 177. P. 189.
Cowan N.C. CT urography for hematuria // Nat. Rev. Urol. 2012. Vol. 9. P. 218.
Cowan N.C., Turney B.W., Taylor N.J. et al. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour // BJU Int. 2007. Vol. 99. P. 1363.
Cura M., Cura A., Bugnone A. Role of magnetic resonance imaging in patient selection for uterine artery embolization // Acta Radiol. 2006. Vol. 47. P. 1105.
Damilakis J., Maris T., Karantanas A. An update on the assessment of osteoporosis using radiologic techniques // Eur. Radiol. 2007. Vol. 17. P. 1591.
Dashe J.S., Twickler D.M. Fetal imaging / Cunningham F.G., Leveno K.J., Bloom S.L. et al. Williams Obstetrics. New York: McGraw- Hill Education, 2018. 213 p.
Davis J.D. Prevention, diagnosis, and treatment of venous thromboembolic complications of gynecologic surgery // Am. J. Obstet. Gynecol. 2001. Vol. 184. P. 759.
DePriest P.D., Shenson D., Fried A. et al. A morphology index based on sonographic findings in ovarian cancer // Gynecol. Oncol. 1993. Vol. 51. P. 7.
Dietz H.P. Mesh in prolapse surgery: an imaging perspective // Ultrasound Obstet. Gynecol. 2012. Vol. 40. P. 495.
Dietz H.P. Quantification of major morphological abnormalities of the levator ani // Ultrasound Obstet. Gynecol. 2007. Vol. 29. P. 329.
Dietz H.P. Pelvic floor ultrasound: a review // Clin. Obstet. Gynecol. 2017. Vol. 60. P. 58.
Dooms G.C., Hricak H., Tscholakoff D. Adnexal structures: MR imaging // Radiology. 1986. Vol. 158. P. 639.
Dueholm M., Lundorf E., Hansen E. et al. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis // Fertil. Steril. 2001. Vol. 76. P. 588.
Eckersley R.J., Sedelaar J.P., Blomley M.J. et al. Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma // Prostate. 2002. Vol. 51. P. 256.
Ekerhovd E., Wienerroith H., Staudach A. et al. Preoperative assessment of unilocular adnexal cysts by transvaginal ultrasonography: a comparison between ultrasonographic morphologic imaging and histopathologic diagnosis // Am. J. Obstet. Gynecol. 2000. Vol. 184. P. 48.
Exacoustos C., Pizzo A., Lazzeri L. et al. Three-dimensional hysterosalpingo contrast sonography with gel foam: methodology and feasibility to obtain 3-dimensional volumes of tubal shape // J. Minim. Invasive Gynecol. 2017. Vol. 24. P. 827.
Fedele L., Dorta M., Brioschi D. et al. Magnetic resonance evaluation of double uteri // Obstet. Gynecol. 1989. Vol. 74. P. 844.
Fielding J.R. MR imaging of m?llerian anomalies: impact on therapy // AJR 1996. Vol. 167. P. 1491.
Fleischer A.C., Harvey S.M., Kurita S.C. et al. Two-/three-dimensional transperineal sonography of complicated tape and mesh implants // Ultrasound. 2012. Vol. Q 28. P. 243.
Fleischer A.C., Lyshchik A., Jones H.W. Jr. et al. Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings // J // Ultrasound. Med. 2008. Vol. 27. P. 1011.
Fleischer A.C., Rodgers W.H., Kepple D.M. et al. Color Doppler sonography of ovarian masses: a multiparameter analysis // J // Ultrasound. Med. 1993. Vol. 12. P. 41.
Forstner R., Hricak H. Congenital malformations of uterus and vagina // Radiology. 1994. Vol. 34. P. 397.
Frei K.A., Kinkel K., Bonel H.M. et al. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging — a meta-analysis and Bayesian analysis // Radiology. 2000. Vol. 216. P. 444.
Friera A., Gimenez N.R., Caballero P. et al. Deep vein thrombosis: can a second sonographic examination be avoided? // AJR 2002. Vol. 178. P. 1001.
Froeling V., Scheurig-Muenkler C., Hamm B. et al. Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata results of symptom control and health-related quality of life 40 months after treatment // Cardiovasc. Intervent. Radiol. 2012. Vol. 25. P. 523.
Gandhi S., Brown M., Wong J. et al. MR contrast agents for liver imaging: what, when, how // Radiographics. 2006. Vol. 26. P. 1621.
Ghi T., Casadio P., Kuleva M. et al. Accuracy of three-dimensional ultrasound in diagnosis and classification of congenital uterine anomalies // Fertil. Steril. 2009. Vol. 92. P. 808.
Gjelsteen A., Ching B.H., Meyermann M.W. et al. CT, MRI, PET, PET/CT, and ultrasound in the evaluation of obstetric and gynecologic patients // Surg. Clin. North Am. 2008. Vol. 88. P. 361.
Goh A.S., Ng D.C. Clinical positron emission tomography imaging — current applications // Ann. Acad. Med. Singapore. 2003. Vol. 32. P. 507.
Gross B.H., Silver T.M., Jaffe M.H. Sonographic features of uterine leiomyomas: analysis of 41 proven cases // J // Ultrasound. Med. 1983. N. 2. P. 401.
Gupta M.K., Khatri G., Bailey A. et al. Endoluminal contrast for the abdominal and pelvic magnetic resonance imaging // Abdom. Radiol. (NY) 2016. Vol. 41. N. 7. P. 1378.
Hanley M., Steigner M.L., Ahmed O. et al. ACR Appropriateness Criteria®: suspected lower-extremity deep vein thrombosis // J. Am. Coll. Radiol. 2018. Vol. 15. N. 11S. P. S413.
Havrilesky L.J., Wong T.Z., Secord A.A. et al. The role of PET scanning in the detection of recurrent cervical cancer // Gynecol. Oncol. 2003. Vol. 90. P. 186.
Hegde A., Aguilar V.C., Davila G. Levator ani defects in patients with stress urinary incontinence: three-dimensional endovaginal ultrasound assessment // Int. Urogynecol. J. 2017. Vol. 28. P. 85.
Hindley J., Gedroyc W.M., Regan L. et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results // AJR 2004. Vol. 183. P. 1713.
Hricak H., Chang YCF, Thurnher S: Vagina: evaluation with MR imaging. I. Normal anatomy and congenital anomalies // Radiology. 1988. Vol. 169. P. 169.
Hricak H., Gatsonis C., Chi D. et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651 – Gynecologic Oncology Group 183 // J. Clin. Oncol. 2005. Vol. 23. N. 36. P. 9329.
Hricak H., Gatsonis C., Conkley F. et al. Early invasive cervical cancer: CT and MRI imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and interobserver variability // Radiology. 2007. Vol. 245. P. 491.
Hricak H., Powell C.B., Yu K.K. et al. Invasive cervical carcinoma: role of MR imaging in pretreatment work-up—cost minimization and diagnostic efficacy analysis // Radiology. 1996. Vol. 198. P. 403.
Hricak H., Stern J.L., Fisher M.R. et al. Endometrial carcinoma staging by MR imaging // Radiology. 1987. Vol. 162. P. 297.
Hricak H., Tscholakoff D., Heinrichs L. et al. Uterine leiomyomas: correlation of MR histopathologic findings, and symptoms // Radiology. 1986. Vol. 158. P. 385.
Hwang M., Lyshchik A., Fleischer A. Molecular sonography with targeted microbubbles: current investigations and potential applications // Ultrasound. 2010. Vol. Q 26. P. 75.
Jain K.A. Prospective evaluation of adnexal masses with endovaginal gray-scale and duplex and color Doppler US: correlation with pathologic findings // Radiology. 1994. Vol. 191. P. 63.
Jankowski J.T., Spirnak J.P. Current recommendations for imaging in the management of urologic traumas // Urol. Clin. North. Am. 2006. Vol. 33. P. 365.
Jayasinghe Y., Rane A., Stalewski H. et al. The presentation and early diagnosis of the rudimentary uterine horn // Obstet. Gynecol. 2005. Vol. 105. P. 1456.
Jeong Y., Outwater E.K., Kang H.K. Imaging evaluation of ovarian masses // Radiographics. 2000. Vol. 20. P. 144.
Jergas M., Genant H.K. Current methods and recent advances in the diagnosis of osteoporosis // Arthritis. Rheum. 1993. Vol. 36. P. 1649.
Jokubkiene L., Sladkevicius P., Valentin L. Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses?// Ultrasound Obstet. Gynecol. 2007. Vol. 29. P. 215.
Juweid M.E., Cheson B.D. Positron-emission tomography and assessment of cancer therapy // N. Engl. J. Med. 2006. Vol. 354. P. 496.
Kang S.K., Reinhold C., Atri M. et al. ACR appropriateness criteria® staging and follow-up of ovarian cancer // J. Am. Coll. Radiol. 2018. Vol. 15. N. 5S. P. S198.
Kaplan F.S. Prevention and management of osteoporosis // Clin. Symp. 1995. P. 47.
Keizer A.L., Nieuwenhuis L.L., Twisk J.W. et al. Role of 3-dimensional sonography in the assessment of submucous fibroids: a pilot study // J. Ultrasound. Med. 2018. Vol. 37. P. 191.
Khalife S., Falcone T., Hemmings R. et al. Diagnostic accuracy of transvaginal ultrasound in detecting free pelvic fluid // J. Reprod. Med. 1998. Vol. 43. P. 795.
Khatri G., Bailey A.A., Bacsu C. et al. Influence of rectal gel volume on defecation during dynamic pelvic floor magnetic resonance imaging // Clin. Imaging. 2015. Vol. 39. N. 6. P. 1027.
Kim M., Kim S., Kim N. et al. Long-term results of uterine artery embolization for symptomatic adenomyosis // AJR 2007. Vol. 188. P. 176.
Kinkel K., Hricak H., Lu Y. et al. US characterization of ovarian masses: a meta-analysis // Radiology. 2000. Vol. 217. P. 803.
Kumar N., Khatri G., Xi Y. et al. Valsalva maneuvers versus defecation for MRI assessment of multi-compartment pelvic organ prolapse. San Diego: American Roentgen Ray Society Annual Meeting, 2014.
Kupesic A., Plavsic B.M. 2D and 3D hysterosalpingo-contrast-sonography in the assessment of uterine cavity and tubal patency // Eur. J. Obstet. Gynecol. Reprod. Biol. 2007. Vol. 113. P. 64.
Kurjak A., Schulman H., Sosic A. et al. Transvaginal ultrasound, color flow, and Doppler waveform of the postmenopausal adnexal mass // Obstet. Gynecol. 1992. Vol. 80. P. 917.
Lee J.K.T., Gersell D.J., Balfe D.M. et al. The uterus: in vitro MR anatomic correlation of normal and abnormal specimens // Radiology. 1985. Vol. 157. P. 175.
Legendre G., Gervaise A., Levaillant J.M. et al. Assessment of three-dimensional ultrasound examination classification to check the position of the tubal sterilization microinsert // Fertil. Steril. 2010. Vol. 94. P. 2732.
Lensing A.W., Prandoni P., Brandjes D. et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography // N. Engl. J. Med. 1989. Vol. 320. P. 342.
Levine D., Brown D.L., Andreotti R.F. et al. Management of asymptomatic ovarian and other adnexal cysts imaged at ultrasound: Society of Radiologists in Ultrasound consensus conference statement // Ultrasound. 2010. Vol. Q 26. P. 121.
Lieng M., Qvigstad E., Dahl G.F. et al. Flow differences between endometrial polyps and cancer: a prospective study using intravenous contrast-enhanced transvaginal color flow Doppler and three-dimensional power Doppler ultrasound // Ultrasound Obstet. Gynecol. 2008. Vol. 32. P. 935.
Lo Monte G., Capobianco G., Piva I. et al. Hysterosalpingo contrast sonography (HyCoSy) let’s make the point! // Arch. Gynecol. Obstet. 2015. Vol. 291. P. 19.
Low R.N., Carter W.D., Saleh F. et al. Ovarian cancer: comparison of findings with perfluorocarbon-exchanged MR imaging, In-111-CYT-103 immunoscintigraphy, and CT // Radiology. 1995. Vol. 195. P. 391.
Lubich L.M., Alderman M.G., Ros P.R. Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide // Magn. Reson. Imaging. 1991. N. 9. P. 331.
Luciano D.E., Exacoustos C., Luciano A.A. Contrast ultrasonography for tubal patency // J. Minim. Invasive Gynecol. 2014. Vol. 21. P. 994.
Macura K.J. Magnetic resonance imaging of pelvic floor defects in women // Top Magn. Reson. Imaging 2006. Vol. 17. P. 417.
Maglinte D.D., Gage S.N., Harmon B.H. et al. Obstruction of the small intestine: accuracy and role of CT in diagnosis // Radiology. 1993. Vol. 188. P. 61.
Majeed A., Divyashree P.S., Rao K.A. Perifollicular vascularity in poor ovarian responders in In-vitro fertilization cycles // J. Hum. Reprod. Sci. 2018. Vol. 11. P. 242.
Makled A.K., Elmekkawi S.F., El-Refaie T.A. et al. Three-dimensional power Doppler and endometrial volume as predictors of malignancy in patients with postmenopausal bleeding // J. Obstet. Gynaecol. Res. 2013. Vol. 39. P. 1045.
Mark A.S., Hricak H., Heinrichs L.W. Adenomyosis and leiomyoma: differential diagnosis by means of magnetic resonance imaging // Radiology. 1987. Vol. 163. P. 527.
Mavrelos D., Naftalin J., Hoo W. et al. Preoperative assessment of submucous fibroids by three-dimensional saline contrast sonohysterography // Ultrasound Obstet. Gynecol. 2011. Vol. 38. P. 350.
McCarthy S., Tauber C., Gore J. Female pelvic anatomy: MR assessment of variations during the menstrual cycle and with use of oral contraceptives // Radiology. 1986. Vol. 160. P. 119.
Mishell D.R. Jr., Stenchever M.A., Droegemueller W, et al. Comprehensive Gynecology. St. Louis: Mosby, 1997. 691 p.
Molander P., Sjoberg J., Paavonen J. et al. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease // Ultrasound Obstet. Gynecol. 2002. Vol. 17. P. 233.
Moore W., Khatri G., Madhuranthakam A. et al. Added value of diffusion-weighted acquisitions in MRI of the abdomen and pelvis // AJR 2014. Vol. 202. P. 995.
Moreno C.C., Beland M.D., Goldfarb S. et al. ACR Appropriateness Criteria®: acute onset flank pain — suspicion of stone disease. Reston: American College of Radiology, 2015.
Moschos E., Twickler D.M. Does the type of intrauterine device affect conspicuity and position evaluation with 2D and 3D ultrasound imaging? // AJR 2011. Vol. 196. P. 1439.
Navve D., Hershkovitz R., Zetounie E. et al. Medial or lateral location of the whirlpool sign in adnexal torsion: clinical importance // J. Ultrasound. Med. 2013. Vol. 32. P. 1631.
Needleman L., Cronan J.J., Lilly M.P. et al. Ultrasound. for lower extremity deep venous thrombosis: multidisciplinary recommendations from the Society of Radiologists in Ultrasound consensus conference // Circulation. 2018. Vol. 137. N. 14. P. 1505.
Neitlich J.D., Foster H.E., Glickman M.G. et al. Detection of urethral diverticula in women: comparison of a high resolution fast spin echo technique with double balloon urethrography // J. Urol. 1998. Vol. 159. P. 408.
Ni J., Han B., Liang J. et al. Three-dimensional 3D ultrasound combined with power Doppler for the differential diagnosis of endometrial lesions among infertile women // Int. J. Gynaecol. Obstet. 145. P. 212, 2019.
Nieuwenhuis L.L., Hermans F.J., Bij de Vaate A.J. et al. Three-dimensional saline infusion sonography compared to two-dimensional saline infusion sonography for the diagnosis of focal intracavitary lesions // Cochrane Database Syst. Rev. 2017. N. 5. P. CD011126.
Novellas S., Chassang M., Delotte J. et al. MRI characteristics of the uterine junctional zone: from normal to the diagnosis of adenomyosis // AJR 2011. Vol. 196. P. 1206.
Nylander M., Fr?ssing S., Bjerre A.H. et al. Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-M?llerian hormone // Acta Radiol. 2017. Vol. 58. P. 997.
Ohel I., Sheiner E., Aricha-Tamir B. et al. Three-dimensional power Doppler ultrasound in ovarian cancer and its correlation with histology // Arch. Gynecol. Obstet. 2010. Vol. 281. P. 919.
Outwater E.K., Siegelman E.S., Van Deerlin V. Adenomyosis: current concepts and imaging considerations // AJR 1998. Vol. 170. P. 437.
Pannu H.K. Magnetic resonance imaging of pelvic organ prolapse // Abdom. Imaging. 2002. Vol. 27. P. 660.
Park W., Park Y.J., Huh S.J. et al. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer // Jpn. J. Clin. Oncol. 2005. Vol. 35. P. 260.
Peng C., Liu L.Z., Zheng W. et al. Can quantitative contrast-enhanced ultrasonography predict cervical tumor response to neoadjuvant chemotherapy? // Eur. J. Radiol. 2016. Vol. 85. P. 2111.
Peres Fagundes P.A., Chapon R., Olsen P.R. et al. Evaluation of three-dimensional SonoAVC ultrasound for antral follicle count in infertile women: its agreement with conventional two-dimensional ultrasound and serum levels of anti-M?llerian hormone // Reprod. Biol. Endocrinol. 2017. Vol. 15. P. 96.
Pisal N., Sindos M., O’Riordian J. et al. The use of spinal needle for transcervical saline infusion sonohysterography in presence of cervical stenosis // Acta. Obstet. Gynecol. Scand. 2005. Vol. 84. P. 1019.
Rajan D., Margau R., Kroll R. et al. Clinical utility of ultrasound versus magnetic resonance imaging for deciding to proceed with uterine artery embolization for presumed symptomatic fibroids // Clin. Radiol. 2011. Vol. 66. P. 57.
Reinhold C., Atri M., Mehio A.R. et al. Diffuse uterine adenomyosis: morphologic criteria and diagnostic accuracy of endovaginal sonography // Radiology. 1995. Vol. 197. P. 609.
Reinhold C., McCarthy S., Bret P.M. et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation // Radiology. 1996. Vol. 199. P. 151.
Reuter K.L., Daly D.C., Cohen SM: Septate versus bicornuate uteri: errors in imaging diagnosis // Radiology. 1989. Vol. 172. P. 749.
Romosan G., Valentin L. The sensitivity and specificity of transvaginal ultrasound with regard to acute pelvic inflammatory disease: a review of the literature // Arch. Gynecol. Obstet. 2014. Vol. 289. P. 705.
Sala E., Rockall A., Freeman S. et al. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know // Radiology. 2013. Vol. 266. P. 718.
Santoro G.A., Wieczorek A.P., Dietz H.P. et al. State of the art: an integrated approach to pelvic floor ultrasonography // Ultrasound Obstet. Gynecol. 2011. Vol. 37. P. 381.
Sassone A.M., Timor-Tritsch I.E., Artner A. et al. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy // Obstet. Gynecol. 1991. Vol. 78. P. 70.
Scalea T.M., Rodriquez A., Chiu W.C. et al. Focused assessment with sonography for trauma (FAST) results from an international consensus conference // J. Trauma. 1999. Vol. 46. P. 466.
Schaer G.N., Koechli O.R., Schuessler B. et al. Perineal ultrasound for evaluating the bladder neck in urinary stress incontinence // Obstet. Gynecol. 1995. Vol. 85. P. 220.
Seshadri S., Khalil M., Osman A. et al. The evolving role of saline infusion sonography (SIS) in infertility // Eur. J. Obstet. Gynecol. Reprod. Biol. 2015. Vol. 185. P. 66.
Siegelman ES, Outwater EK: Tissue characterization in the female pelvis by means of MR imaging // Radiology. 1999. Vol. 212. P. 5.
Song Y., Yang J., Liu Z. et al. Preoperative evaluation of endometrial carcinoma by contrast-enhanced ultrasonography // BJOG 2009. Vol. 116. P. 294.
Stoelinga B., Hehenkamp W.J.K., Brolmann H.A.M. et al: Real-time elastography for assessment of uterine disorders // Ultrasound Obstet. Gynecol. 2014. Vol. 43. P. 218.
Stoelinga B., Hehenkamp W.J.K., Nieuwenhuis L.L. et al. Accuracy and reproducibility of sonoelastography for the assessment of fibroids and adenomyosis, with magnetic resonance imaging as reference standard // Ultrasound. Med. Biol. 2018. Vol. 44. P. 1654.
Stumpf P.G., March C.M. Febrile morbidity following hysterosalpingography: identification of risk factors and recommendations for prophylaxis // Fertil. Steril. 1980. Vol. 33. P. 487.
Subak L.L., Hricak H., Powell C.B. et al. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging // Obstet. Gynecol. 1995. Vol. 86. P. 43.
Taylor L.S., Porter B.C., Rubens D.J. et al. Three-dimensional sonoelastography: principles and practices // Phys. Med. Biol. 2000. Vol. 45. P. 1477.
Tempany C., Dou K., Silverman S. et al. Staging of advanced ovarian cancer: comparison of imaging modalities report from the Radiological Diagnostic Oncology Group // Radiology. 2000. Vol. 215. P. 761.
Thurmond A.S. Selective salpingography and fallopian tube recanalization // AJR 1991. Vol. 156. P. 33.
Timmerman D., Testa A.C., Bourne T. et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group // J. Clin. Oncol. 2005. Vol. 23. P. 8794.
Timmerman D., Valentin L., Bourne T. et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis. N. IOTA) group // Ultrasound Obstet. Gynecol. 2000. Vol. 16. P. 500.
Timmerman D., Van Calster B., Testa A. et al. Predicting the risk of malignancy in adnexal masses based on the simple rules from the International Ovarian Tumor Analysis group // Am. J. Obstet. Gynecol. 2016. Vol. 214. P. 424.
Timor-Tritsch I.E., Lerner J.P., Monteagudo A. et al. Transvaginal sonographic markers of tubal inflammatory disease // Ultrasound Obstet. Gynecol. 1998. Vol. 12. P. 56.
Tinkanen H., Kujansuu E. Doppler ultrasound findings in tubo-ovarian infectious complex // J. Clin. Ultrasound. 1993. Vol. 21. P. 175.
Titton R.L., Gervais D.A., Hahn P.F. et al. Urine leaks and urinomas: diagnosis and imaging guided intervention // Radiographics. 2003. Vol. 23. P. 1133.
Togashi K., Ozasa H., Konishi I. Enlarged uterus: differentiation between adenomyosis and leiomyoma with MRI // Radiology. 1989. Vol. 171. P. 531.
Troiano R., McCarthy S. M?llerian duct anomalies: imaging and clinical issues // Radiology. 2004. Vol. 233. P. 19.
Twickler D.M., Forte T.B., Santos-Ramos R. et al. The Ovarian Tumor Index predicts risk for malignancy // Cancer. 1999. Vol. 86. P. 2280.
Twickler D.M., Moschos E. Ultrasound and assessment of ovarian cancer risk // AJR 2010. Vol. 194. P. 322.
Valentin L. Gray scale sonography, subjective evaluation of the color Doppler image and measurement of blood flow velocity for distinguishing benign and malignant tumor of suspected adnexal origin // Eur. J. Obstet. Gynecol. Reprod. Biol. 1997. Vol. 72. P. 63.
Vellucci F., Regini C., Barbanti C. et al. Pelvic floor evaluation with transperineal ultrasound: a new approach // Minerva Ginecol. 2018. Vol. 70. P. 58.
Wang X.W., Tian J.W., Wang H.K. Diagnostic value of transvaginal color Doppler ultrasound on endometrial lesions // Eur. J. Gynaecol. Oncol. 2016. Vol. 37. P. 842.
Wang Y., Qian L. Three- or four-dimensional hysterosalpingo contrast sonography for diagnosing tubal patency in infertile females: a systematic review with meta-analysis // Br. J. Radiol. 2016. Vol. 89. N. 1063. P. 20151013.
Weiner Z., Thaler I., Beck D. et al. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging // Obstet. Gynecol. 1992. Vol. 79. P. 159.
Wolfman D.J., Ascher S.M. Magnetic resonance imaging of benign uterine pathology // Top Magn. Reson. Imaging 2006. Vol. 17. P. 399.
Wong T.Z., Jones E.L., Coleman R.E. Positron emission tomography with 2-deoxy-2-[18F]fluoro-d-glucose for evaluating local and distant disease in patients with cervical cancer // Mol. Imaging. Biol. 2004. Vol. 6. P. 55.
Wu H.M., Chiang C.H., Huang H.Y. et al. Detection of the subendometrial vascularization flow index by three-dimensional ultrasound may be useful for predicting the pregnancy rate for patients undergoing in vitro fertilization-embryo transfer // Fertil. Steril. 2003. Vol. 79. P. 507.
Wu Y., Peng H., Zhao X. Diagnostic performance of contrast-enhanced ultrasound for ovarian cancer: a meta-analysis // Ultrasound. Med. Biol. 2015. Vol. 41. P. 967.
Xie M., Zhang X., Yu M. et al. Evaluation of the cervix after cervical conization by transvaginal elastography // J. Ultrasound. Med. 2018. Vol. 37. P. 1109.
Yamashita Y., Torashima M., Hatanaka Y. et al. Adnexal masses: accuracy of characterization with transvaginal US and precontrast and postcontrast MR imaging // Radiology. 1995. Vol. 194. P. 557.
Yamashita Y., Torashima M., Takahashi M. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications // Radiology. 1993. Vol. 189. P. 721.
Yitta S., Hecht E., Mausner E. et al. Normal or abnormal? Demystifying uterine and cervical contrast enhancement at multidetector CT // Radiographics. 2011. Vol. 31. P. 647.
Yu N.C., Raman S.S., Patel M. et al. Fistulas of the genitourinary tract: a radiologic review // Radiographics. 2004. Vol. 24. P. 1331.
Zheng W., Chen K., Peng C. et al. Contrast-enhanced ultrasonography vs MRI for evaluation of local invasion by cervical cancer // Br. J. Radiol. 91. P. 20170858, 2018.
Zollner U., Specketer M.T., Dietl J. et al. 3D-Endometrial volume and outcome of cryopreserved embryo replacement cycles // Arch. Gynecol. Obstet. 2012. Vol. 286. P. 517.
Труды отечественных авторов при подготовке статей по гинекологии для пользователей сайта - не использовались, так как их вы всегда можете найти в библиотеках.
